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Effects of a Postpartum Sleep Schedule on Childless Women’s Sleep, Circadian 
Amplitude, Daytime Sleepiness, Performance, and Mood 
 
Amanda L. McBean, M.S. 
OBJECTIVES: A complex process of physiological and environmental changes during 
the postpartum period confounds our understanding of the discrete impacts of 
postpartum sleep fragmentation. The aim of this dissertation was to isolate the effects of 
postpartum sleep fragmentation by manipulating the sleep of childless women in the 
laboratory to model a postpartum sleep fragmentation schedule. Actigraphically and 
polysomnographically-recorded sleep, daytime functioning, mood, and melatonin 
amplitude were quantified. 
METHODS: Eleven healthy, childless women (25.4 [SD±2.3] years, 72.7% white, 
$23,000 [SD±$11,000] household income) contributed continuous wrist actigraphy and 
daily psychomotor vigilance test (PVT) for one baseline week followed by 3 consecutive 
nights of overnight polysomnography: an adjustment/sleep disorder screening night, a 
baseline night, and a night of experimental sleep fragmentation during which they were 
awakened 3 times for 30-35mins each. During nocturnal awakenings, women engaged 
in a standardized protocol that included feeding, changing, and rocking a doll in dim 
light (<3 lux) to model postpartum motor activity and postures. First-morning baseline 
and fragmentation night voids were collected for 6-sulphatoxymelatonin assays to 
estimate circadian rhythm amplitude. Baseline and post-fragmentation Multiple Sleep 
Latency Tests (MSLT) and Profile of Mood States Surveys (POMS) were administered. 
A final week of at-home actigraphy monitoring, daily PVTs, and POMS captured 
recovery. 
RESULTS: Sleep time did not change between baseline (M=461±28min) and sleep 
fragmentation nights (M=448±34min; p=.17), while sleep efficiency decreased 
(M=90.9%±6.1%; M=74.4%±3.9%, respectively; p<.001). Frequency of PVT lapses 
increased significantly from baseline (M=1.62±1.83) to the week after fragmentation 
(M=2.72±1.76; p=.01). Mood disturbance increased from baseline (M=-1.00±7.10) to 
after sleep fragmentation (M=8.55±12.9; p=.037). MSLT scores increased from baseline 
(M=13.1±3.54) to after sleep fragmentation (M=16.3±3.51; p=.02), indicating decreased 
daytime sleepiness. No changes in time spent in nocturnal sleep stages, 6-
sulphatoxymelatonin concentration and actigraphy-defined total sleep time were found 
after sleep fragmentation compared to baseline. 
CONCLUSIONS: The current study is the first to experimentally examine the effects of a 
simulated postpartum sleep disturbance schedule on aspects of physiology and 
behavior. Results suggest no changes in measured physiological components of a 
single night of simulated postpartum sleep fragmentation, but significant deficits in mood 
and neurobehavioral performance. Disruption of sleep continuity in the absence of 
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Legend 
AANAT = arylkylamine N-acetyltransferase 
AASM = American Academy of Sleep Medicine 
ANOVA = Analysis of Variance 
aMT6 = 6-sulphatoxymelatonin 
EDS = Excessive Daytime Sleepiness 
ELISA = Enzyme-linked Immunosorbent Assay 
M-E = Morningness-Eveningness 
MSLT = Multiple Sleep Latency Test 
PLMA = Periodic Limb Movements with associated Arousals 
PLMS = Periodic Limb Movements in Sleep 
PMDD = Premenstrual Dysphoric Disorder 
POMS = Profile of Mood States Survey 
PSG = Polysomnography 
PVT = Psychomotor Vigilance Test 
TMD = Total Mood Disturbance 
TNF-α = Tumor Necrosis Factor Alpha 
TST = Total Sleep Time 
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Effects of a Postpartum Sleep Schedule on Childless Women’s Sleep, Circadian 
Amplitude, Daytime Sleepiness, Performance, and Mood 
Introduction 
The maternal postpartum period is characterized by sleep fragmentation, which 
is associated with daytime impairment, mental health disturbances, and changes in 
melatonin levels. While sleep fragmentation can cause each of these outcomes, new 
mothers vary in the severity to which they experience these outcomes. These individual 
differences are likely a result of a complex process of individual physiological and 
environmental differences, so the relative contribution of sleep fragmentation to each of 
these outcomes is unknown. The purpose of this study was to understand the basic 
impact of sleep fragmentation, common during the maternal postpartum period, on 
sleep architecture, nocturnal melatonin, mood, daytime sleepiness, performance, and 
recovery. This was done by applying a maternal postpartum sleep schedule to healthy 
childless women, and modeling postpartum nocturnal activities such as light exposure, 
posture, and movement. The innovative component of the study that is expected to 
contribute to the advancement of our understanding and interventions was studying 
childless adult women in the sleep laboratory. This allowed for isolation of the specific 
effects of a single night of sleep fragmentation from postpartum physiological and 
environmental changes, while controlling for nocturnal activities, light levels, and 
postural changes; such stringent control is difficult to logistically and ethically use 
among a true postpartum population.  
The study protocol (diagrammed in Figure 1 below for a single participant) was 
used to monitor each of 11 childless women’s sleep and performance at home for one 
week before she came into the sleep laboratory for an assessment of daytime 
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sleepiness, followed by three consecutive nights in the laboratory. The first night served 
as both an adjustment night to the sleep laboratory and as a screening for sleep 
disorders; the second night was used as a measure of baseline sleep; the third night 
was the experimental sleep fragmentation night. After the baseline and experimental 
sleep fragmentation nights, morning urine samples were collected to estimate nocturnal 
melatonin levels. Another assessment of daytime sleepiness occurred the day 
proceeding the experimental sleep fragmentation night, followed by a week of at-home 
monitored sleep and daily performance assessments and every-other-day mood 
surveys to quantify recovery. 
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Figure 1. Study protocol for a single participant 
*Baseline Assessments 
^Lab adjustment and sleep disorder screening night for participant (data not used) 
Actigraphy=At home sleep with fixed bed times (10pm-12pm) and rise times (6am-8am) 
PVT=Psychomotor Vigilance Test (performance assessment) 
MSLT=Multiple Sleep Latency Test (in lab daytime sleepiness assessment) 
POMS=Profile of Mood States survey 
S=In lab sleep periods recorded using polysomnography 
M=Urine 6-sulphatoxymelatonin samples (overnight & first morning void) 
 
 
Day Time of Day 
 22  23  24     1     2     3     4     5     6     7      8     9    10   11   12   13    14   15   16   17    18   19   20   21  22 
1 Actigraphy* PVT*             
2 Actigraphy* PVT*             
3 Actigraphy* PVT*             
4 Actigraphy* PVT*             
5 Actigraphy* PVT*             
6 Actigraphy* PVT*             
7 Actigraphy* PVT* MSLT*/POMS*      
8   S^               
9   S*               
M*  
10   S  S  S  S  MSLT/POMS      
M 
11 Actigraphy PVT             
12 Actigraphy PVT      POMS      
13 Actigraphy PVT             
14 Actigraphy PVT      POMS      
15 Actigraphy PVT             
16 Actigraphy PVT      POMS      
17 Actigraphy PVT             
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To provide a context for the current study, the introduction is split into two major 
sections. The first section provides a background on normative sleep and maternal 
postpartum sleep fragmentation. The second section focuses on the effects of sleep 
disturbance on the circadian system of the sleep-wake cycle, sleep architecture, 
daytime sleepiness, mood, and recovery. 
Sleep and Postpartum Sleep Disturbances 
Normal Sleep 
Sleep occurs in cycles, each cycle lasting about 70-120 minutes (Kryger, Roth, & 
Dement, 2011). The human sleep cycle begins with three stages of non-Rapid Eye 
Movement (NREM) sleep (stages N1, N2, and N3), then transitions into REM sleep. If 
the sleep cycle is interrupted at any point, it must start from the beginning. While a 
thorough understanding of the function of these components remains largely unknown, 
particular attention and importance has been placed on REM sleep and stage N3 sleep, 
the deepest stage of NREM sleep characterized by delta EEG waves. There is support 
for a role of stage N3 in the restorative aspect of sleep, as specific disruption to stage 
N3 leads to increased daytime sleep propensity (Dijk, Groeger, Stanley, & Deacon, 
2010). REM sleep likely plays a role in cognitive functioning, especially the 
consolidation of new memories (for review see McCoy & Strecker, 2011). 
Sleep Fragmentation 
 Sleep fragmentation is a type of sleep disturbance in which there is a disruption 
in sleep continuity. This differs from sleep deprivation (a reduction in total sleep time) in 
that the quality of sleep is compromised, not the quantity. Existing research indicates 
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both sleep deprivation and sleep fragmentation yield similar adverse health 
consequences. Experimentally induced sleep fragmentation among healthy adults 
causes poorer mood (Bonnet, 1985), impaired daytime functioning (Bonnet, 1985; 
Durmer & Dinges, 2005; Zaharna & Guilleminault, 2010), hormonal alterations (Zaharna 
& Guilleminault, 2010), and daytime fatigue (Zaharna & Guilleminault, 2010) 
comparable to the impact of sleep deprivation. Moreover, as sleep deprivation alters the 
concentration of nocturnal melatonin (a biomarker of the central circadian clock) 
(Cajochen, Jewett, & Dijk, 2003; Kavčič et al, 2011), sleep fragmentation may also 
disrupt the concentration of melatonin. These specific effects of sleep disturbances will 
be presented in more detail in the following sections. Yet the protocol of experimental 
sleep fragmentation used in these studies differs from the fragmentation among 
postpartum mothers, who experience much longer periods of consolidated sleep, but 
also longer periods of wakefulness. The effects of postpartum sleep fragmentation are 
not fully understood. 
Postpartum Sleep Disturbances 
Postpartum mothers experience sleep disturbances, characterized by sleep 
fragmentation, during the early postpartum period (Gay, Lee, & Lee, 2004; Hunter, 
Pychnovsky, & Yount, 2009; Montgomery-Downs, Insana, Clegg-Kraynok, & Mancini, 
2010). At postpartum week 2, new mothers obtain approximately 7.2 hours of total sleep 
time, despite spending about 9 hours in bed (Montgomery-Downs et al., 2010). Thus, 
they experience reduced sleep efficiency and increases in wake after sleep onset (Gay 
et al., 2004; Matsumoto, Shinkoda, Kang, Seo, 2003).  
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Mechanisms for Postpartum Sleep Disturbances  
Infant Sleep 
 Postpartum maternal sleep is interrupted by frequent infant nocturnal awakenings 
(Santiago, Nolledo, Kinzler, & Santiago, 2001). Infants are not born with a sleep-wake 
rhythm that promotes one consolidated nocturnal sleep period. Instead they exhibit 
polyphasic sleep, whereby they have multiple sleep periods across a 24-hour period. A 
stable sleep-wake rhythm in infants develops over time, as sleep periods gradually 
lengthen so that most infants can “sleep through the night” about three months after 
birth (de Weerd & van den Bossche, 2003; Kleitman & Engelmann, 1953). These 
frequent infant nocturnal awakenings have implications for maternal sleep as there are 
strong correlations between maternal nocturnal awakenings and infant movements 
indicative of wake (Nishihara, Horiuchi, Eto, & Uchida, 2002; Wulff & Siegmund, 2000). 
Postpartum Physiological Changes  
New mothers experience physiological changes throughout pregnancy and the 
postpartum period that may be impacting their sleep and mental health above and 
beyond the nocturnal infant demands. Steroid hormones such as estrogen, 
progesterone, and cortisol increase during pregnancy and abruptly decrease after 
parturition (Bonnar, Franklin, Nott, & McNeilly, 1975; Tulchinsky, Hobel, Yeager, & 
Marshall, 1972; West & McNeilly, 1979); this abrupt transition has posited to be 
associated with mood disturbances (Bloch et al., 2000; Bloch et al., 2005; Doornbos et 
al., 2009). Estrogen and progesterone have sleep-promoting effects (Ross, Murray, & 
Steiner, 2005). Estrogen decreases sleep onset latency, nocturnal awakenings and 
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REM sleep, while increasing total sleep time. Progesterone is sedative, decreasing 
wakefulness and latency to NREM sleep as well as decreasing REM sleep. High cortisol 
levels are associated with stress and depressive symptoms (Manber & Armitage, 1999). 
 Mothers who choose to breastfeed may be further altering their sleep and their 
infant’s sleep in unique ways from formula feeding mothers. Breastfeeding may have a 
soporific effect on infants as a result of the rise of 4 nucleotides present in breast milk 
that have circadian rhythms (Sánchez et al., 2009). Prolactin levels, which rise 
throughout pregnancy, return to pregravid levels in a few weeks among non-lactating 
women. However, breastfeeding induces the release of oxytocin, a hormone that 
stimulates pituitary lactotrophic cells and preserves high prolactin levels, which in turn is 
strongly associated with sleep (Sassin, Frantz, Weitzman, & Kapen, 1972). Therefore, 
hormonal changes postpartum may be further altering sleep and mental health, and 
perhaps their impact may even be protective of maternal sleep. 
 Physiological changes during the postpartum period that may impact sleep and 
mental health are not limited to hormonal changes. Most new mothers complain of at 
least one physical health symptom during the early postpartum period (Ansara, Cohen, 
Gallop, Kung, & Schei, 2005). The most commonly reported symptoms include general 
pain, headaches, fatigue, backaches, abdominal pain, bowel incontinence, and breast 
soreness (Cheng & Li, 2008; Webb et al., 2008). While there is a lack of literature 
specifically on postpartum physical pain and sleep, more than half of adults with chronic 
pain also experience sleep disturbances (Marty et al., 2008; McCracken & Iverson, 
2002; Rohrbeck, Jordan, & Croft, 2007). Further, postpartum physical health conditions 
are associated with emotional well-being and depressive symptoms (Webb et al., 2008), 
EFFECTS OF A POSTPARTUM SLEEP SCHEDULE   8 
 
which is bidirectionally associated with sleep (Dørheim, Bondevik, Eberhard-Gran, & 
Bjorvatn, 2009; McCoy, 2011; Posmontier, 2008; Ross et al., 2005). 
Postpartum Environmental Changes 
 The postpartum period is also characterized by adjustment to a new parenting 
role that includes caring for an infant and coping with the resultant emotional and social 
change (Brage Hudson, Elek, & Fleck, 2001). Child-care responsibilities and lack of 
knowledge related to parenting can be sources of frustration and fatigue for new 
mothers (Kanotra et al., 2007). Postpartum fatigue is indirectly associated with stress 
via depressive symptoms and sleep quality (Groër et al., 2005; Song, Change, Park, 
Kim, & Nam, 2010). New mothers may vary substantially in their adjustment to the 
postpartum period as a result of available social support. New mothers report social 
networks as their primary source of support (Leahy-Warren, 2007), and social support is 
a recognized buffer for stressful life events and predictor of emotional and physical well-
being (Hung, 2004). Thus, the impact of the postpartum period on sleep and mental 
health is not limited to physiological changes, but also includes the environment. 
Effects of Sleep Disturbance 
Circadian Rhythm 
 An established model of sleep postulates that sleep and wake are regulated by 
two fundamental processes: a homeostatic sleep drive (Process S) and a circadian 
timing system (Process C) (Borbély, 1982). The homeostatic process regulates sleep 
propensity on the basis of prior wake time. The circadian system governs the timing of 
nearly all 24-hour endogenous biological processes within the body, including sleep and 
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wake. These two processes interact such that as sleep drive accumulates across the 
waking day, an increasing circadian wake drive compensates for the buildup of 
sleepiness and results in a relatively steady level of wakefulness across the day. As the 
need for sleep dissipates in the first few hours of nocturnal sleep, an increase in 
circadian sleep drive during the second half of the night allows sleep to continue (Dijk & 
von Schantz, 2005). When these processes are not in harmony, mood, daytime 
functioning, and physical health may be impaired (Mendlewicz, 2009; Mosendane, 
Mosendane, & Raal, 2008; Reid & Zee, 2009).  
The circadian system is controlled by a central circadian pacemaker in the 
suprachiasmatic nuclei (SCN) of the hypothalamus (Eastman, Mistleberger, & 
Rachtschaffen, 1984; Ralph, Foster, Davis, & Menaker, 1990). The SCN are paired 
nuclei, each containing approximately 10,000 small, highly dense neurons. Individual 
neurons within the SCN are capable of producing circadian oscillations, which 
synchronize remarkably to generate coordinated outputs that regulate overt rhythms. 
These oscillatory rhythms are self-sustaining in conditions absent of time cues 
(zeitgebers) and are regulated by a network of transcriptional-translational feedback 
loops (Reppert & Weaver, 2001). 
The period of these rhythms is not exactly 24-hours, and under conditions in 
which there are no time cues, the rhythms will drift slightly each day (Czeisler, et al., 
1999; Duffy et al., 2011). Most adults have a period longer than 24 hours - the average 
circadian period is approximately 24 hours 9 minutes in length. However, about 35% of 
females and 14% of males have circadian periods shorter than 24 hours (Duffy et al., 
2011). Under typical conditions, the circadian rhythm is reset on a daily basis by 
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zeitgebers, which allows the circadian rhythm to maintain a periodicity that matches the 
24-hour solar day (Pittendrigh & Daan, 1976). The circadian rhythm is most vulnerable 
to time cues when they are not expected to be present, such as light exposure during 
the subjective night (Roenneberg, Daan, & Merrow, 2003). The restorative benefits of 
sleep are most pronounced when sleep occurs during the typical sleep hours shaped by 
an individual’s circadian rhythm (Gillette & Abbott, 2005). 
 Melatonin serves as a biomarker for the circadian rhythm and is measurable in 
humans in plasma, saliva, and urine through its urinary metabolite, 6-
sulphatoxymelatonin (aMT6) (Benloucif et al., 2008). Melatonin is an indole hormone 
secreted by the pineal gland with a robust circadian rhythm: concentrations of melatonin 
are stable and very low during the day, with an abrupt rise a couple hours before 
habitual bedtime, peaking overnight, and decreasing to the low daytime level close to 
habitual rise time. Melatonin is synthesized from serotonin primarily in the pineal gland. 
Daytime levels of serotonin are high, but decrease at night in the presence of melatonin 
formation due to its consumption by this process. Arylkylamine N-acetyltransferase 
(AANAT), a critical enzyme in the conversion of serotonin to melatonin, is considered 
the rate-limiting factor in the production of melatonin. AANAT follows a circadian rhythm 
of low activity during the day, limiting daytime production of melatonin (for review see 
Borjigin, Zhang, & Calinescu, 2012; Ganguly, Coon, & Klein, 2002). The activity of 
AANAT is regulated by the suprachiasmatic nuclei (SCN) of the hypothalamus, the site 
of the central circadian pacemaker. 
 Postpartum women experience a disruption in their circadian rhythm (Matsumoto 
et al., 2003; Nishihara et al, 2002; Thomas & Burr, 2006; Wulff & Siegmund, 2000). 
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Thus far, the postpartum circadian rhythm has primarily been characterized by a blunted 
pattern of nocturnal levels of melatonin compared to nulliparous controls (Thomas & 
Burr, 2006) and pregnancy levels (Wierrani, Hlawka, Kroiss, Grünberger, 1997). These 
altered melatonin levels may be associated with postpartum mood disorders such as 
depression (Anderson, 2010; Parry et al., 2008). However, the cause of the altered 
postpartum circadian rhythm is not known.  
Changes in hormones during the postpartum period may cause disruption of the 
circadian rhythm. During pregnancy, estradiol and progesterone levels were inversely 
related to melatonin (Pang et al., 1987). While no human studies relate prolactin, 
oxytocin, and melatonin postpartum, a study in early postpartum ewes found prolactin 
levels were inversely related to melatonin (Molik, Misztal, Romanowicz, Zieba, 2010)  
 In addition, sleep disturbances may influence melatonin levels. The impact of 
total sleep deprivation on melatonin varies across studies. Total sleep deprivation 
combined with continuous 50 lux light exposure and sedentary activity (regularly seated) 
overnight reduced overall nocturnal melatonin production compared to normal sleep 
nights (Kavčič  et al, 2011). Conversely, another study among young adult males found 
no effect of sleep deprivation on nocturnal melatonin levels (von Truer, Norman, & 
Armstrong, 1996). These studies did not address sleep fragmentation, which would 
relate to postpartum women. Yet, similar contradictory evidence exists regarding the 
impact of sleep fragmentation, as seen in patients with obstructive sleep apnea (OSA), 
on nocturnal melatonin levels. Wikner et al. (1997) studied males with OSA before and 
after treatment, and healthy control males. Melatonin did not differ before and after 
treatment of OSA, nor did the melatonin levels in OSA patients differ from healthy 
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controls. Conversely, Hernández et al. (2007) found that patients with OSA did not have 
a nocturnal melatonin peak, but healthy controls did.  
The distinction between postpartum sleep disturbance and hormonal changes on 
melatonin patterns has not been made. The current study manipulated the sleep of 
childless women using a postpartum-like schedule in order to isolate the impact of 
postpartum sleep disturbance on a major metabolite of melatonin, aMT6. 
Sleep Architecture 
Sleep fragmentation can impact the amount of time spent in specific sleep 
stages. Among healthy adults who were awakened by an audiometer every minute 
throughout the sleep period (and verbally confirmed each awakening), the percentage 
of time spent in stages N2, N3, and REM sleep was significantly decreased, while the 
time spent in stage N1 sleep was increased compared to a baseline night (Bonnet, 
1985). Total sleep time on the sleep fragmentation night was only one hour less than 
the total sleep time on the baseline night. Similarly, another study that experimentally 
induced sleep fragmentation among healthy adults by playing auditory tones at on 
average every 2 minutes caused a change in the amount of time spent in specific sleep 
stages while preserving total sleep time. During the fragmentation night time spent in 
stage N3 and REM were significantly reduced, and time spent in stages N1 and N2 
were significantly increased compared to the screening night (Roerhs et al., 1994). 
 There is still limited research about time spent in certain sleep stages 
postpartum. While one study found postpartum women spend significantly more time in 
stage N3 and less time in REM than during pregnancy (Driver & Shapiro, 1992), another 
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study suggested no differences in sleep stages between pregnancy and postpartum 
(Nishihara & Horiuchi, 1998). The most recent study compared postpartum women to 
childless controls and found postpartum women spent a greater percentage of time in 
stage N3 than controls (Nishihara et al., 2004). These authors suggest that this increase 
was more likely to be explained by the release of prolactin secretion promoted by 
breast-feeding than the rebound effect of sleep disturbance because there was no 
change in the time spent in stage N3 among women at postpartum weeks 9-13 on 
uninterrupted nights of sleep versus nights when they awoke for infant caregiving. 
Therefore, the current study aimed to characterize sleep architecture as a result of the 
sleep fragmentation experienced by women during the early postpartum period, without 
the mitigating effects of hormonal changes by using a sample of childless, adult women. 
Daytime Sleepiness 
 Excessive daytime sleepiness (EDS) is a common consequence of sleep 
disturbance and refers to an increased propensity to fall asleep and suffer sleep attacks 
when sleep is not desired (Benbadis, 2005). EDS can have devastating consequences 
including decreased performance, diminished intellectual capacity, and increased risk 
for vehicular and industrial accidents (Carskadon & Dement, 1987; Philip et al., 2010). 
Daytime sleepiness has been the primary recognized cause for many high profile 
disasters, including Three Mile Island, Chernobyl, Challenger explosion, and Exxon 
Valdez (Walsh, Dement, & Dinges, 2005). Of particular concern, perception of 
sleepiness is not a reliable indicator of sleep onset in monotonous situations, 
suggesting people are not reliable judges of their own propensity to fall asleep during 
inappropriate times (Herrmann et al., 2010).  
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 Sleep disorders commonly associated with EDS include sleep insufficiency, 
sleep apnea, narcolepsy, idiopathic hypersomnia, and periodic limb movement 
disorders (Benbadis, 2005). Sleep apnea and periodic limb movement disorders are 
both disorders characterized by sleep fragmentation, supporting the notion that sleep 
fragmentation can result in daytime sleepiness. In the laboratory, when experimental 
sleep fragmentation was produced among healthy adults by the presentation of auditory 
tones at approximately 2-minute intervals, objective levels of daytime sleepiness were 
increased (Roehrs et al, 1994). 
The mechanism through which sleep fragmentation causes daytime sleepiness, 
while preserving total sleep time, is not yet understood. Recent lines of evidence 
suggest roles for the activation of specific cytokines in mediating the relation between 
sleep fragmentation and daytime sleepiness. Tumor necrosis factor alpha (TNF-α) is 
involved in the pathogenesis of many chronic inflammatory diseases and immune 
responses (Popa, Netea, can Riel, can der Meer, Stalenhoef,, 2007; Zhang et al., 
2009). Cytokines such as TNF-α also have established roles in the regulation of sleep. 
Administration of exogenous TNF-α induces sleepiness and produces excessive sleep 
whereas inhibition of TNF-α decreases the onset of spontaneous sleep (for review see 
Krueger, 2008). Mice lacking the TNF-α receptor did not show cognitive dysfunction or 
changes in biomarkers of sleep propensity (Kaushal, Ramesh, & Gozal, 2012; Ramesh 
et al., 2012) after chronic experimental sleep fragmentation, in contrast to control mice. 
Total sleep time and sleep architecture was preserved during the sleep fragmentation 
protocol (Kaushal et al., 2012), suggesting the TNF-α pathway works independently of 
these variables.  
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Adenosine, an inhibitory neuromodulator, may also serve as a potential mediator 
between sleep fragmentation and daytime sleepiness. Experimental systemic and 
intracerebral injection of adenosine has increased sleep (Benington, Kodali, & Heller, 
1995; Portas, Thakkar, Rainnie, Greene, & McCarley, 1997), whereas adenosine 
antagonists (ex. caffeine) increase arousal (Fredholm, Battig, Holmén, Nehlig, & 
Zvartau, 1999). Adenosine may facilitate sleep through the inhibition of neurons related 
to arousal in the basal forebrain (Porkka-Heiskanen et al., 1997). Levels of adenosine 
have been shown to rise in the basal forebrain during sleep deprivation (Porkka-
Heiskanen et al., 1997; Porkka-Heiskanen, Strecker, & McCarley, 2000) as well as 
during sleep fragmentation (McKenna et al., 2007). However, the role of cytokines and 
adenosine in the mediating the relation between sleep fragmentation and daytime 
sleepiness is still unclear. Cytokines and adenosine may be driving the effects of sleep 
disturbance, providing a compensatory response, or providing an additional unknown 
function. 
Postpartum mothers, who are an otherwise healthy population without pre-
existing sleep disorders, experience both a unique form of fragmented sleep that differs 
from the sleep fragmenting disorders, but appear to experience similar consequences. 
Postpartum mothers experience impaired neurobehavioral performance throughout the 
first 12 postpartum weeks compared to childless controls (Insana & Montgomery-
Downs, 2013). At 6-weeks postpartum, mothers fall asleep on a Multiple Sleep Latency 
Test (MSLT) (an objective measure of daytime sleepiness) in an average of 11.8 
minutes, a time that is borderline moderate daytime sleepiness that may or may not be 
at pathological levels (Insana & Montgomery-Downs, 2012). Furthermore, there are 
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large individual differences in the daytime sleepiness values – the standard deviation for 
these women was 4.6 minutes with a range of 3.1-18.6 minutes. What is unclear is how 
much of this variation has to do with the actual sleep disturbances experienced versus 
physiological (e.g. postpartum physical and hormonal changes) and environmental 
factors (e.g. life changes associated with caring for an infant). The current study 
attempted to control the environmental factors that could be influencing sleepiness, and 
used a non-postpartum sample to control for the physiological changes characterizing 
this period, to provide a clearer understanding of how sleep fragmentation during the 
early postpartum period impacts daytime sleepiness and performance.  
Mood 
 Both sleep deprivation and sleep fragmentation can have negative effects on 
mood. One week of experimental chronic restriction of sleep to 4-5 hours per night 
resulted in worsened mood as reported on the Profile of Mood States (POMS) total 
mood disturbance, and subscales of fatigue, vigor, confusion, and tension (Dinges et al, 
1997). Similar mood disturbances are seen after experimental sleep fragmentation; two 
nights of consecutive sleep fragmentation caused by awakenings from an auditory tone 
every minute throughout the nights degraded mood to levels that were greater than a 
single night of total sleep deprivation, despite obtaining over 5 hours of total sleep time 
each night (Bonnet, 1985). 
 Postpartum mood disturbances are prevalent; 85% of mothers report transient 
changes in mood during the first postpartum week (Ross et al., 2005), and an estimated 
7-17% of women are diagnosed with postpartum depression after the fourth postpartum 
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week (Figueiredo & Conde, 2011; Horowitz, Murphy, Gregory, Wojcik, 2009; Milgrom et 
al., 2008; Ross et al., 2005; Pearlstein, Howard, Salisbury, Zlotnick, 2009). The adverse 
outcomes of postpartum depression affect the entire family unit and include: disruption 
in the marriage, increased neglect in child caregiving, delayed child development, and a 
poorer mother-infant relationship (Field, 2010; McCoy, 2011; Righetti-Veltema, Conne-
Perreard, Bousquet, & Manzano, 2002). In many cases, a diagnosis of postpartum 
depression triggers recurring or chronic episodes of depression throughout the woman’s 
life (Cooper & Murray, 1995; Goodman, 2004). 
 Yet the etiology of postpartum mood disturbances is a complex system that is not 
clearly understood. While the literature explained above suggests a role for sleep 
disturbance in causing mood disruptions postpartum, evidence also supports 
physiological and social causes of mood disruptions. Postpartum women experience 
marked changes in concentrations of sex steroids after birth, which could provide a 
possible mechanism for mood disruptions (for review see Russell, Douglas, & Ingram, 
2000). Moreover, postpartum mood disruption could be caused by social factors, such 
as low levels of social support or the recent experience of a stressful event (Robertson, 
Grace, Wallington, & Stewart, 2004). Postpartum mood disturbances likely do not have 
a single cause, but rather are a combination of exposure to multiple risk factors. The 
current study examined the role of a single night of postpartum-like sleep disturbance 
on mood. 
EFFECTS OF A POSTPARTUM SLEEP SCHEDULE   18 
 
Recovery from Sleep Disturbance 
 The trajectory of recovery after sleep disturbance is not well elucidated. 
Neurobehavioral deficits caused by 5 consecutive nights of 4 hours of time in bed 
improved in a dose-response relation with increasing time in bed on a subsequent 
recovery night. However, even after 10 hours in bed after the imposed sleep restriction, 
neurobehavioral deficits remained, suggesting either a longer sleep period or multiple 
nights are required to return to baseline levels of performance (Banks, Van Dongen, 
Maislin, & Dinges, 2010). 
 Moreover, the average postpartum woman experiences chronic sleep 
fragmentation until their infant has developed a consolidated sleep-wake schedule that 
allows for sleeping through the night, which occurs around the age of three months 
(Kleitman & Engelmann, 1953; de Weerd & van den Bossche, 2003). Yet when, or even 
if, a woman recovers from this sleep disturbance is unknown. Preliminary data from our 
lab indicate mothers with one child between the ages of 6-30 months old did not differ in 
objective daytime sleepiness from mothers with one 6-week old child, despite the fact 
their sleep had normalized to the level of controls. The current study provided basic 
information concerning the impact of a single night of postpartum-like sleep disturbance 
on total sleep time, neurocognitive performance, and mood for a week following the 
sleep disturbance. 
Statement of the Problem 
The purpose of the current study was to understand the basic effects of a single 
night of sleep fragmentation, as seen during the maternal early postpartum period, on 
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nocturnal sleep stages, daytime impairment and recovery, mood, and melatonin levels. 
Only one night of sleep fragmentation occurred in the current study because of interest 
in the effects of acute sleep fragmentation, Multiple nights of sleep disturbance would 
begin to capture a different phenomenon, recovery sleep, whereby any alterations in 
sleep architecture on the first sleep disturbance night impact sleep architecture 
differently on subsequent nights (e.g. REM rebound, or increases in REM sleep) 
(Kilduff, Kushida, & Terao, 2005; Roehrs et al., 2004). Understanding the impact of 
acute postpartum sleep fragmentation, and whether there are even changes to sleep 
architecture on just one night, was the goal of the current study; examining multiple 
nights captures a different phenomenon that was beyond the scope of the current study. 
 New mothers experience sleep fragmentation that is associated with daytime 
impairment, mental health disturbances, and blunted levels of melatonin. However, 
there have also been large individual differences reported on each of these measures 
among new mothers. These individual differences are likely a result of individual 
physiological and environmental differences. No study has yet controlled for the 
physiological and environmental factors that could be impacting some of these 
outcomes, likely due to the difficulties of studying this population in a laboratory and the 
logistic and ethical barriers to changing and manipulating their routine. This study 
attempted to overcome these barriers and provide a basic understanding of the effects 
of a night of postpartum-like sleep fragmentation by manipulating the sleep of healthy, 
adult women without children to resemble what is observed during the early postpartum 
period. This study design allowed for the isolation of the postpartum-like sleep 
disturbances effects, without the confounding physical, hormonal, or social changes as 
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a result of giving birth, helping further understand the specific role of the sleep 
disturbance on specified outcomes. 
Further, it is expected that data from the current study will provide a foundation 
for future studies in which environmental changes such as nocturnal light exposure, 
posture, and activities performed simultaneously to infant feeding/caregiving, can be 
systematically manipulated to determine their individual contributions to sleep and 
related outcomes. It also provides a basis for future studies of the role postpartum 
hormonal changes have on sleep, daytime sleepiness, performance, and mood. 
Understanding the relative importance of these factors to sleep-related outcomes is 
expected to guide postpartum interventions. 
Research Questions and Hypotheses 
RQ#1: How does a single night of experimentally-simulated postpartum sleep 
disturbance affect nocturnal melatonin release among healthy nulliparous 
women? 
H1: One night of postpartum-like sleep disturbance will cause a suppression of 6-
sulphatoxymelatonin compared to the baseline night.  
This hypothesis was based on the blunted nocturnal levels of melatonin that have been 
described among postpartum women (Thomas & Burr, 2006). Other support for this 
hypothesis can be found in some studies that showed decreased total nocturnal levels 
of melatonin after experimental sleep deprivation (Kavčič  et al., 2011) and absence of a 
nocturnal melatonin peak among patients with obstructive sleep apnea, a sleep disorder 
characterized by sleep fragmentation (Hernandez et al., 2007). Among patients with 
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Alzheimer’s Disease (AD), a decreased amplitude of the melatonin rhythm has been 
hypothesized to explain the irregular sleep-wake rhythm and fragmented sleep 
symptoms (for review, see Sack et al., 2007).  
RQ#2: How does a single night of experimentally-simulated postpartum sleep 
disturbance affect sleep architecture among healthy nulliparous women? 
H2a: Percentage of time spent in stage N1 sleep will be increased in the 
experimental night compared to the baseline night. 
H2b: Percentage of time spent in stage N2 sleep will be increased in the 
experimental night compared to the baseline night. 
H2c: Percentage of time spent in stage N3 sleep will be reduced in the 
experimental night compared to the baseline night. 
H2d: Percentage of time spent in REM sleep will be reduced in the experimental 
night compared to the baseline night. 
Each time there is a disruption in the sleep cycle (such as an awakening), the sleep 
cycle must begin from the beginning - you cannot pick up in the sleep stage you left off 
in prior to the awakening. Thus, multiple awakenings from sleep fragmentation would 
theoretically lead to more time spent in stages at the beginning of the sleep cycle (N1 
and N2) and less time spent in stages at the end of the sleep cycle (N3 and REM). 
Experimental sleep fragmentation studies support this, showing significant increases in 
time spent in stage N1 sleep, and decreases in time spent in stages N3 and REM sleep 
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(Bonnet, 1985; Roehrs et al., 1994). However, stage N2 sleep was increased in one 
study (Bonnet, 1985) and decreased in another (Roehrs et al., 1994). 
RQ#3: How does a single night of experimentally-simulated postpartum sleep 
disturbance impact daytime sleepiness among healthy nulliparous women? 
H3: One night of experimental sleep disturbance will cause greater daytime 
sleepiness on a Multiple Sleep Latency Test than baseline night. 
This hypothesis was based on widespread evidence that sleep disturbance results in 
daytime sleepiness (Benbadis, 2005). Sleep disorders characterized by sleep 
fragmentation cause excessive daytime sleepiness (Benbadis, 2005); postpartum 
women, who also experience fragmented sleep, demonstrate daytime sleepiness 
(Insana & Montgomery-Downs, 2012). Finally, experimental sleep fragmentation causes 
increased levels of daytime sleepiness (Roehrs et al., 1994). 
RQ#4: How does a single night of experimentally-simulated postpartum sleep 
disturbance impact the next week’s sleep, performance, and mood among healthy 
nulliparous women? 
H4a: Experimental sleep disruption will cause increased actigraphy-measured 
total sleep time on the proceeding at-home recovery night, compared to baseline 
at-home total sleep time, and total sleep time will decrease to baseline levels 
after the first recovery night. 
This hypothesis was based on the 10-20% increase in total sleep time the night 
following partial and total sleep deprivation (Benoit et al., 1980; Webb & Agnew, 1975). 
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The night directly following experimental sleep fragmentation also had a greater total 
sleep time; however, this was not significant (Bonnet, 1985). 
H4b: Experimental sleep disruption will cause worse performance on a 
psychomotor vigilance test (PVT) on the morning after experimental sleep 
fragmentation compared to baseline condition, and will gradually improve to 
baseline levels across the recovery week. 
This hypothesis was based on the worsening performance seen after sleep disruption, 
and that after one night of recovery sleep, performance levels are still significantly 
worse than controls (Banks et al., 2010; Sallinen et al., 2008). This suggests multiple 
recovery nights are necessary for performance to return to baseline, but the number of 
nights necessary is not yet clear. 
H4c: Experimental sleep disruption will cause higher POMS total mood 
disturbance scores the day after experimental sleep fragmentation compared to 
baseline condition, and will gradually improve to baseline levels across the 
recovery week. 
This hypothesis was based on research that indicates sleep disturbance can impair 
mood (Bonnet, 2005). One night of sleep deprivation decreased mood, and took 2 
recovery nights to return to baseline (Ikegami et al., 2009). Acute experimental sleep 
fragmentation decreased mood among healthy adults (Bonnet, 1985; Martin, Engleman, 
Deary, & Douglas, 1996). Among women within the first postpartum week, the amount 
of sleep lost at night was directly associated with worse mood (Swain, O’Hara, Starr, & 
Gorman,1997). 
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Supplemental Analyses: If any of the hypotheses concerning the worsening of mood, 
PVT performance, or MSLT scores were supported, supplemental analyses comparing 
these results to existing data from postpartum women in the lab were conducted in 
order to determine how effects of the single sleep fragmentation night compares to 
postpartum outcomes on these measures. A previous longitudinal study conducted in 
the lab continuously monitored sleep and daily PVT among new mothers across the first 
12 postpartum weeks; mood surveys were administered biweekly and an MSLT was 
conducted among 21 of these women at postpartum week six. The number of lapses 
worsened across the early postpartum period, supporting a cumulative effect of sleep 
disturbance during this period, and lapses were significantly higher than controls at 
each week (Insana et al, 2013). At six weeks postpartum, mothers experienced 
moderate sleepiness on the MSLT (sleep onset latency average = 11.8, SD = 4.6) 
(Insana, 2010). Mood scores on the POMS were collected after odd-numbered weeks. 




 Participants were healthy, childless women between the ages of 18-40. Only 
women were included in the current study because of the hormonal differences between 
men and women and the inadequate power of this small sample-size study to split 
analyses based on sex. Furthermore, women were chosen over men because mothers 
are still the primary parent responsible for nocturnal infant caregiving (Insana, Garfield, 
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& Montgomery-Downs, in press). Participants were excluded based on the following 
criteria (see Figure 2):  
• History, current diagnosis, or high risk for major depressive disorder (≥16 score 
on the Center for Epidemiologic Studies Depression (CES-D) Scale (Radloff, 
1977) (Appendix A)  
• Symptoms of Premenstrual Dysphoric Disorder (PMDD), in accordance with the 
DSM-IV (Appendix A) 
• Blindness or any type of ocular light perception dysfunction (including color 
blindness) 
• Significant medical illness that put the participant under routine physician care  
• Sleep disorder identified by a history of or symptoms (Appendix A) 
• Drug or alcohol use (≥3 score on the Drug Use Questionnaire [DAST-10]; ≥3 
score on the Short Michigan Alcohol Screening Test [SMAST]) (Appendix A) 
• Irregular sleep schedule, travel across more than 1 time zone, or working night 
shifts within the month before the study  
• Extreme sleep periods – habitual bedtimes prior to 9pm or later than 2am, and 
wake times prior to 6am or later than 11am 
• Excessive napping, defined as napping ≥3 times during the baseline week 
• Excessive daytime sleepiness, or a score of ≤8 on a baseline Multiple Sleep 
Latency Test (MSLT) 
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< 6 hours total sleep 
time any night 
No 
> 1 hour deviation from 
set bed (9pm-2am) and 




Depressive symptoms (≥ 16 
on CES-D) 
No 
Significant medical illness 
No 
Symptoms of sleep disorder 
according to sleep disorders 
symptoms screening survey 
No 
Drug use (≥ 3 DAST-10) 
No 
Alcohol use (≥ 3 SMAST) 
No 
Travel more than 1 time zone 
or night shift work within the 
month before the study 
No 
Habitual bed and wake times 
outside of 10-12pm and 6-
8am 
Meets Phone Screening 
Requirements! 







Figure 2. Study eligibility decision tree. 
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Participants who were deemed ineligible for the study on the basis of high risk for major 
depressive disorder or symptoms of a sleep disorder were provided with information 
about resources for evaluation and treatment. 
 Recruitment occurred via word-of-mouth and community advertisements placed 
to encourage a large range of socioeconomic status and diverse racial/ethnic 
participants. The target sample size was n=10, which was derived from effect sizes 
calculated based on previous studies. G Power Version 3.1 was used to derive required 
sample sizes (Faul, Erdfelder, Land, & Buchner, 2007). Power = 0.8 and a two-tailed 
alpha = 0.05 were the criterion in each of the analyses. 
Power Analyses 
Target power for melatonin analyses: 
Based on effect sizes (d=2.30 and d=2.78) calculated from previous studies that 
compared melatonin suppression of acute light exposure during a 30 minute nocturnal 
awakening (Bojkowski et al., 1987; Gooley et al., 2011, respectively) and between 
constant light or dim light overnight, a sample size of n=4-5 for a within-subjects design 
was required to achieve necessary power. 
Target power for Polysomnography (PSG) analyses: 
Previous studies of changes in sleep architecture after one night of experimental 
sleep fragmentation have used sample sizes of 36 subjects (Roehrs et al., 1994) and 11 
subjects (Bonnet, 1985). However, based on the effect sizes from Roehrs et al. (1994) 
comparing changes in percentage of time spent in SWS (d = 2.11) and time spent in 
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stage 1 sleep (d = 1.06) between baseline and sleep fragmentation nights, a sample 
size of N = 5-10 for a within subjects design was required to achieve necessary power. 
Target power for MSLT analyses: 
A sample size of approximately 10 per group (n=20) is typically reported in the 
literature when examining differences in levels of sleepiness between groups using the 
MSLT (Geisler et al, 2006; Afifi et al 2005). Based on an effect size (d = 1.02) calculated 
using a larger sample of 36 healthy young adults’ changes in MSLT scores after a night 
of experimental sleep fragmentation, a sample size of N = 10 for a within-subjects 
design was required to achieve necessary power. 
Target power for recovery analyses: 
Sample sizes of roughly 10-15 subjects are commonly reported in the literature 
when examining recovery sleep and performance from sleep disturbances (Bonnet, 
1985; Axelsson et al, 2008; Sallinen et al, 2008; Wehrens, Hampton, Kerkhofs, & 
Skene, 2012). Within these studies, large effect sizes (range: d = 0.87-2.24) have been 
reported, suggesting adequate sample sizes to examine recovery from experimental 
sleep fragmentation. 
The above power analyses and previous study success supported the attained 
sample size of N = 11 for a within subjects design with 80% power at an alpha = 0.05. 
Compensation 
 Each participant received $15 per week of at-home actigraphy based sleep/wake 
monitoring, plus an additional $20 for each overnight PSG and daytime MSLT, resulting 
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in $130 for each participant’s successful completion of the entire study. Participants who 
failed to complete the entire study were compensated at half the rate for each 
successful portion she did complete. 
Measures 
Urinary 6-sulphatoxymelatonin (aMT6s) 
 At the end of the baseline and experimental sleep fragmentation nights, 
participants provided an overnight urine sample to assess 6-sulphatoxymelatonin 
(aMT6s), the primary metabolite of melatonin, to answer Research Question #1. The 
hormone melatonin is the gold standard biomarker for the central circadian clock and 
can be measured in plasma, saliva, or urine (Benloucif, et al., 2008). The main 
advantage of using urinary aMT6s is sampling can occur overnight without any 
additional sleep disturbances. Saliva sampling overnight would require participants to 
be awake at night to provide samples. Levels of melatonin in plasma are about three 
times greater than that of saliva, allowing for a greater resolution and sensitivity than 
saliva or urine methods. If sampling occurs at frequent intervals, plasma melatonin 
provides the strongest signal of the three methods, making it a preferred method. 
However, plasma sampling is a more expensive and invasive procedure that requires 
an indwelling catheter inserted into a participant’s vein to allow continuous collection of 
plasma melatonin overnight. 
Urinary aMT6 does not allow for the precise measurement of evening melatonin 
onset, but allows for assessing overnight concentration of melatonin (Matthews, Guerin, 
& Wang, 1991). After participants’ morning void, urine was stirred in the commode hat 
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to homogenize and then divided into two approximately 50 mL aliquots. One aliquot was 
transported to WVU Hospital’s Laboratories, where the sample was centrifuged and 
creatinine was analyzed within 24 hours by the Alkaline Picrate method. aMT6 
concentration varies with urine volume, yet in practice, urine volume can be difficult to 
accurately measure. However, renal clearance can be estimated when urine volume is 
unknown through measurement of creatinine. Creatinine was collected as part of the 
current study’s protocol to control for urine concentration in order to overcome 
methodological issues in obtaining exact urine volumes (Klante, Brinschwitz, Secci, 
Wollnik, & Steinlechner, 1997). 
The other aliquot was centrifuged the same day as collection in Dr. Kinsey’s 
laboratory in the Life Science Building for 5 minutes at 2000 x g. A 1 mL aliquot was 
pipetted into a small test tube to be stored separately and used for the aMT6 analysis. 
This was to prevent repeated freeze thaw cycles if multiple testing on the urine samples 
was needed. Both samples were immediately stored in a -20°C freezer. Within the 
week, these samples were transferred into a -80°C freezer for long-term storage 
(samples can be stored at ≤-20°C for up to 1 year). Once all samples were collected, 
batch assay was conducted according to ALPCO’s (Salem, New Hampshire) aMT6 
enzyme-linked immunosorbent assay (ELISA) kit’s protocol.  
Overnight Polysomnography (PSG) 
 The established 10-20 system was used to set up participants for PSG (Klem, 
Luders, Jasper, & Elger, 1999). Minimum montage used included central referential 
electroencephalogram C3 and C4 (backup), occipital referential electroencephalogram 
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O1 and O2 (backup), right and left electro-oculogram leads, 2 submental 
electromyogram leads on the participant’s chin, and electrocardiogram. High resolution 
video monitoring simultaneously collected video recording and was used to help score 
sleep. In addition to the minimum montage described above, on the first PSG 
adjustment/screening night, abdominal and thoracic respiratory belts, an oral/nasal 
thermistor, a snore sensor, and a pulse oximeter were used to screen for respiratory 
disorders of sleep. Leg EMG sensors were placed on the anterior tibialis muscles to 
screen for Periodic Limb Movement Disorder. These extra channels provided the data 
necessary to detect a sleep disorder, if present. When the first night of screening 
indicated no sleep disorders, the participant continued in the study and the next two 
nights (baseline and experimental) used the minimal montage to increase ease of 
movement overnight and reduce discomfort of excess wires. The overnight PSG 
protocol allowed for precise examination of time spent in sleep stages (these cannot be 
measured using actigraphy) that is needed to address Research Question #2. 
Multiple Sleep Latency Test (MSLT) 
 The laboratory-based Multiple Sleep Latency Test (MSLT) was used as an 
objective measure of daytime sleepiness, operationally defining the degree of 
sleepiness as sleep latency (Afifi et al., 2005). Daytime sleepiness is a complex system 
unlikely to be easily measured through just one method. Objective measures of 
sleepiness, such as the MSLT and Maintenance of Wakefulness Test (MWT), have 
typically been used in preference over subjective measures, which lack sensitivity and 
specificity (Coelho, Narayansingh, & Murray, 2011). The MSLT is considered the gold 
standard measure of sleepiness and has been used to diagnose narcolepsy and sleep 
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disorders with a secondary presentation of excessive daytime sleepiness (Arand et al., 
2005; Mitler et al., 1979; Van den Hoed et al., 1981). The protocol for the proposed 
study followed standardized, established guidelines for the MSLT (Littner et al., 2005). 
The MSLT required participants’ sleep to be monitored for one to two weeks prior to the 
test via actigraphy or sleep/wake diaries. Participants were asked to refrain from 
caffeine and alcohol the day of the MSLT. On the day of the MSLT, participants came 
into the laboratory and were given four nap opportunities, each spaced at 2 hour 
intervals from each other, with the first nap beginning 1.5-3 hours after termination of 
nocturnal sleep. Each nap opportunity was 20 minutes in duration and participants were 
in a quiet, dark bedroom and instructed to “Please lie quietly, assume a comfortable 
position, keep your eyes closed and try to fall asleep.” The minimum montage described 
above for the second and third overnight PSG was used. High resolution video 
monitoring simultaneously collected video recording and was used to help score sleep 
onset as well as ensure participants remained awake during the breaks between MSLT 
naps. Sleep latency time was defined as the time it takes from lights out to the first 30-
second epoch of any sleep stage using the American Academy of Sleep Medicine’s 
2008 rules for PSG sleep stage scoring. In any of the nap opportunities, if sleep did not 
occur, the sleep latency was recorded as 20 minutes. The outcome measure of the test 
was the average sleep onset latency from the 4 nap opportunities and was used to test 
the hypothesis for Research Question #3, as well as to screen participants at baseline 
for eligibility in the study. Interpretation of the MSLT scores typically follows a ‘rule of 
thumb.’ Average sleep onset latency scores ≤5mins indicate pathological level of 
daytime sleepiness and scores between 10 and 20 minutes are considered normal 
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levels of sleepiness. Scores between 5 and 10 minutes fall into a diagnostic grey area 
(Afifi et al., 2005). The use of a baseline MSLT score of ≤8 as exclusion criteria in the 
current study is based on the definition of sleepiness for diagnostic purposes, as 
identified by the International Classification of Sleep Disorders (AASM, 2005). 
Actigraphy 
Sleep/wake periods were monitored at home using Mini Mitter’s Actiwatch-64 
(AW-64) actigraphs (Bend, Oregon). The actiwatch looks and is worn like a wrist watch 
on the participant’s non-dominant wrist. It uses an accelerometer sensor to interpret 
movement; these data on movement intensity were downloaded onto the laboratory 
computer via a reader. The actiwatch was programmed at the most sensitive 15-epoch 
setting, which allowed up to 11 days of continuous monitoring. Because actiwatches 
record motion like an accelerometer, periods of nocturnal sleep and daytime naps were 
identified using the sleep diary filled out by participants on their personal digital 
assistant (described below) to corroborate data from actigraphy outputs. The Actigraph 
software was used to calculate total sleep time and ensure participants maintained a 
regular sleep schedule during the baseline period, as well as to assess recovery for 
Research Question #4. Actigraphy has been well-validated for detecting sleep/wake 
patterns among adults (Benson et al., 2004; Edinger, Means, Stechuchak, & Olsen, 
2004; Morgenthaler et al., 2007; Sadeh, 2011). Its advantage over the traditional, gold 
standard PSG is that it can conveniently record continuously for long periods of time, 
and it allows for measurement of sleep patterns in the field. It has been correlated with 
PSG for differentiating sleep from wake, with 91% agreement rates (de Souza et al., 
2003). 
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 A Palm Zire 72 handheld personal digital assistant (PDA) was used to collect 
field-based sleep and actiwatch diaries. These diaries behaviorally corroborated 
actigraphy data and are essential to help control artifact that could misidentify periods of 
immobility as sleep (Acebo & LeBourgeois, 2006). Further, an electronic diary was 
chosen over a paper and pencil diary because of improved adherence to filling out logs 
when using an electronic diary compared to paper-and-pencil logs (Stone, Shiffman, 
Schwartz, Broderick, & Hufford, 2002) as well as participants’ reported increased 
preference for the electronic over paper version in recording of behaviors (Lam et al., 
2010) and infant sleep (Müller, Hemmi, Wilhelm, Barr, & Schneider, 2011). 
Psychomotor Vigilance Test (PVT) 
 The psychomotor vigilance test (PVT) was self-administered using the PDA each 
morning within two hours after awakening and prior to the consumption of any caffeine 
to prevent possible caffeine-related or circadian alerting effects (Lim & Dinges, 2008). 
Each test lasted 5 minutes, during which stimuli were presented at random inter-
stimulus intervals. The use of this 5-minute test is supported by a validation of PVTs 
less than 10 minutes in duration (Loh, Lamond, Corrian, Roach, & Dawson, 2004). 
Reaction times were recorded for response to each individual stimulus, and the number 
of lapses (reaction times ≥500ms) was calculated from the reaction times. The PVT has 
become the predominant test of vigilant attention used in sleep research because of its 
high sensitivity to sleep deprivation, predictive ability of performance in simulated driving 
tasks, and relatively minor learning effects (Basner & Dinges, 2011; Jackson, Croft, 
Kennedy, Owens, & Howard, 2013; Lim & Dinges, 2008). The frequency of lapses was 
EFFECTS OF A POSTPARTUM SLEEP SCHEDULE   35 
 
used to assess recovery of performance after experimental sleep fragmentation for 
Research Question #4. 
 Profile of Mood States (POMS) 
 The Profile of Mood States (POMS) (Appendix A) was administered in the 
laboratory prior to and after the experimental sleep fragmentation, and it was given to 
each subject to self-administer at home each day for the recovery week (automatic text 
messages were sent from the research team to remind the women to fill this out). The 
POMS consists of 65 adjectives rated by participants using a 5-point Likert scale. Six 
subscales have been derived from the POMS: tension-anxiety, depression-dejection, 
anger-hostility, fatigue-inertia, confusion-bewilderment, and vigor-activity. Subscale 
ranges vary: tension-anxiety (0–36); depression (0–60); anger-hostility (0–48); fatigue 
(0–28); confusion bewilderment (0–28); and the reverse-scored vigor-activity subscale 
has a range from -32 to 0. A POMS Total Mood Disturbance (TMD) score is derived 
from the addition of the six subscale scores, has a range from -32 to 200, and is an 
indicator of a global dimension of mood disturbance. POMS TMD scores and all but the 
vigor-activity subscale are negative dimensions, so high scores represent worse mood. 
Survey responses reflected the participant’s mood during the past day. Internal 
consistencies of the POMS when administered to adults 17-60 years old ranged from 
0.84 (confusion-bewilderment scale) to 0.95 (depression-dejection scale) (McNair, Lorr, 
& Droppleman, 1992). Scores on the POMS were used to assess recovery of mood 
after experimental sleep fragmentation for Research Question #4.  
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Procedure 
 Once participants were identified, they came into the laboratory where a 
researcher gave a laboratory tour, described the research protocol in full, provided 
instructions for using the equipment (actigraph and PDA), described the surveys, 
collected demographic information, and answered any residual questions from 
participants. Informed consent and a Health Insurance Portability and Accountability Act 
(HIPAA) authorization were administered to participants. The procedure for the study is 
illustrated in Figure 1, and is split into 3 phases.  
Phase I 
 Participants began the study with a 7-day field based protocol, which served both 
to normalize sleep and provide a baseline measurement after which the experimental 
night was compared. Participants were also asked to keep a consistent, approximately 
8-hour sleep period (more if needed) with a bedtime based on habitual sleep periods. 
Participants wore an actigraph on their non-dominant wrist and filled out on their PDA:  
when they put on and took off the actigraph, a sleep diary, and completed a PVT each 
morning within 2 hours after awakening. The nightly sleep time and average daily 
number of lapses on the PVT were averaged across the week to create stable baseline 
measures. 
Phase II  
At the end of the 7-days, participants came into the laboratory for the second 
phase, a laboratory-based protocol. They came into the laboratory about 1-1.5 hours 
after awakening on the 7th day so that research personnel could apply the PSG sensors 
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before the first MSLT nap opportunity (scheduled 1.5-3 hours after awakening that 
morning). Prior to or immediately after the first nap opportunity, a researcher 
downloaded the data from the week of actigraphy to ensure participants followed 
protocol and determine average bedtime, rise time, and time spent in bed (these values 
were used for the in-laboratory nights). Participants underwent the MSLT, conducted 
according to standardized protocol (Littner et al., 2005). Between nap opportunities 
participants remained in the laboratory and engaged in leisure activities such as 
reading, watching a movie, using the internet, or anything else that involved low levels 
of activity. They brought a lunch and snacks, as this was not be provided by the 
researcher team. Participants were continuously monitored with video recording to 
ensure they did not fall asleep between the nap opportunities. Additionally, they filled 
out the POMS survey between naps.  
At the end of the MSLT day, participants who had average sleep onset latencies 
equal to or less than 8 minutes were disqualified from the study. Otherwise, they were 
allowed to go home for a few hours, and then asked to come back about 1.5 hours 
before their habitual bedtime (determined via actigraphy data from baseline week) to get 
set up for the first overnight PSG. Participants slept according to their habitual sleep 
periods determined by baseline actigraphy data. This night served as an adjustment 
night in order to account for the first-night effect, which is a phenomenon by which 
participants experience increased awakenings, decreased time spent in REM sleep, 
longer latencies to SWS and REM, and a greater number of stage changes during the 
first night spent in a sleep laboratory (Agnew, Wilse, Webb, & Williams, 1966). It also 
served to ensure none of the participants had a sleep disorder. Data from this night 
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were not used in subsequent analyses. After the first night, participants had sensors 
removed, left the laboratory, and were instructed to come back that night. During their 
day away from the laboratory, participants refrained from napping, and wore their 
actiwatch.  
The second night of the protocol was conducted in the same manner as the first 
night but was used as a baseline night for subsequent analyses. Urine was also 
collected overnight for the measurement of aMT6. Participants voided urine within 10 
minutes of bedtime. Consistent with other studies collecting overnight aMT6, this pre-
bedtime void was not collected for analysis (Davanipour, Poulsen, Weimann, & Sobel, 
2009; Roach et al., 2005). From that point on, all urine passed during the night was 
collected in a commode hat and remained there at room temperature. At the end of the 
sleep period, participants voided urine into the commode hat. After the pre-bedtime 
urine void, participants were kept in dim light (12 lux in the direction of gaze one meter 
away, or more accurately, 3.5 lux from the participant’s perspective lying in bed, verified 
by a light meter) while bio-calibrations were conducted until lights out. The bedroom 
was completely dark during sleep periods (0 lux). A red light was used in the bathroom if 
participants awakened in the middle of the night to void. Dim and red light were used in 
order to minimize the impact of light on 6-sulphatoxymelatonin (aMT6s) secretion. 
Participants returned home after the second night.  
On the third night, participants again came into the laboratory about 1.5 hours 
before bedtime to get hooked-up for PSG. This night served as the experimental night. 
Based on data from our lab indicating women report an average of 2.9 awakenings 
each night during the second postpartum week (Winser, 2012), and the 
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recommendations from the AAP that breastfed newborns should be fed at intervals 
between 1.5-3 hours, mothers were awakened 3 times throughout the night. Previous 
literature indicates feeding time is approximately 13.8-16 minutes (De Carvalho et al., 
1982; Thoman et al., 1971), but that mothers spend an additional 12 minutes engaged 
with the infant in non-feeding activities (Thoman et al., 1971). Based on the combination 
of these data and literature, it was decided the protocol for the current study would 
consist of 3 awakenings of about 30-35 minutes each, spaced equally apart throughout 
the night. Each participant’s bedtime and habitual time spent in bed was preserved; 
scheduled awakenings added into the sleep period resulted in a rise time that was 1 hr 
30 mins – 1 hr 45 mins later than typical for each participant.  
No published data exist on the activities new mothers engage in at night. The 
current protocol for the 35 minute awakenings was therefore not based on research. 
However, it was based on anecdotal information from mothers and was standardized for 
each participant. Posture and lighting levels (1 lux in the direction of gaze, verified by a 
light meter) during each awakening were kept consistent between participants because 
both changes in posture and lighting levels can impact melatonin levels and sleepiness 
(Cajochen et al., 2005; Deacon & Arendt, 1994; Gooley et al., 2011). Each participant 
was told that they would be awakened three times throughout the night by an audio clip 
of a baby crying via an intercom next to the participant’s bed. The crying baby was 
sufficient to wake each participant for each awakening, confirmed by EEG data. They 
were then given the following standard instructions via the intercom during each of the 
three awakenings: 
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1. Pick up the baby doll, change the doll’s diaper with a diaper that was in the 
participant’s room (5 minutes - participant was standing during the procedure).  
2. Sit in the rocking chair and pretend to feed the baby doll with the bottle provided 
(15 minutes – participant was seated) 
3. Burp the baby (5 minutes – participant was seated) 
4. The participant was then asked to stand and put the baby back down on the 
spare bed, and was allowed to go to the bathroom (if needed) (5 minutes – 
participant was standing) 
5. The researcher entered to fix any PSG sensors that had fallen off, after which the 
participant will be told to go back to bed. 
 The researcher entered the room each time the participant was moved from one 
posture to another to ensure participants did not trip over or drop the equipment in the 
dimly lit room. In some circumstances, the researcher also entered to provide the 
participant with an extra blanket. During all interactions with the participant at night, 
conversation was kept to a minimum. Once participants were awakened in the morning, 
first morning void was collected (and combined with all samples from any time they 
used the bathroom overnight). They remained in the laboratory that day for the second 
MSLT (which began 1.5-3 hours after awakening). The MSLT was conducted as 
described above during the baseline session.  
Phase III  
After the laboratory Phase II, participants went home and their sleep was 
monitored with actigraphy and a sleep diary on the PDA for 7 nights, and they self-
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administered the PVT each morning within 2 hours after awakening (same protocol as 
the first 7 nights of the study, except sleep was ad libitum). The POMS was filled out 
every other day to capture changes in mood during recovery. At the end of the study, a 
researcher picked up the equipment from the participant either in the laboratory or at a 
location convenient for her. After full participation in the study, each participant received 
$130 in compensation.  
Results 
Participants 
Women were recruited via university-wide and the Department of Psychology 
listservs, an ad on Craigslist, and word of mouth between March and November 2013. 
Figure 3 illustrates how many women expressed initial interest and then declined to 
begin or continue participation, or were excluded at various points throughout the study. 
Based on an a priori power analyses, the target sample size was n=10. An extra 
participant was included in case one participant’s data were incomplete or an outlier on 
any measure was found, and had to be excluded post-hoc. As no post-hoc exclusions 
were necessary, 11 women contributed data to the study. Women who completed the 
study were all nulliparous with no reported history or current symptoms of depression, 
as defined by a score of <16 on the CES-D (Radloff, 1977); they did not report 
symptoms of premenstrual dysphoric disorder (PMDD) and all had regular menstrual 
cycles (defined as being confident in their ability to predict when their period will start, to 
the week); they did not work night shifts or travel through >1 time zone during the month 
prior to participating in the study; these women did not report blindness or visual 
impairments that would interfere with the production of melatonin; they did not have a 
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major medical illness for which they received routine physician care; were not smokers; 
they consumed no more caffeine per day than the amount in two 6-oz cups of coffee, 
consumed on average <3 alcoholic drinks per week, and were told not to have any 
alcoholic beverages the day of any overnight polysomnography (PSG).  
Based on the PSG screening night, no participant had any respiratory events. 
Three of the completed participants had periodic limb movements in sleep (PLMS), with 
the highest number of PLMS/hour at 8.3 for one participant (periodic limb movements 
with associated arousals [PLMA]/hour=1.0). The other two had PLMS/hours indices of 
2.6 (PLMA=0.8) and 1.6 (PLMA=0). The International Classification of Sleep Disorders 
(AASM, 2005) requires >15 PLMS/hour along with a clinical sleep disturbance or 
complaint of daytime fatigue before it is considered a sleep disorder. As PLMS are 
common findings on PSG recordings, and none of these participants had clinically 
significant levels of PLMS that were consistent with a disorder, had complaints of 
daytime fatigue, or showed signs of excessive daytime sleepiness (based on recorded 
MSLT scores), all participants’ data were included in the final analyses. 
Demographic characteristics of the total sample are in Table 1. Between-groups 
one-way Analysis of Variances (ANOVA) and chi-square tests were used to analyze 
whether the participants who began but did not complete the study differed from those 
who completed the study. No differences were found between groups on any 
demographic variable or baseline actigraphically-recorded total sleep time.
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*Did not differentiate between those who were unable to participate due to scheduling 
difficulties and those who were no longer interested.  
#Reasons for ineligibility to begin study: on antidepressant medication (n=1), symptoms 
of a sleep disorder (n=2), major medical condition (n=1).  
^Reasons for ineligibility to continue study: sleep/wake times differed across baseline 
week by >3 hours (n=1), score <8 on MSLT (n=4), sleep disorder symptoms on 
screening night (n=1). 
Women who expressed interest in the study (n=189) 
Women who completed the phone screening (n=27) 
Excluded* (n=162) 
Excluded (n=8)  
   Based on ineligibility
#
 (n=4) 
   Scheduling conflict arose prior to start of study (n=4) 
Women who began the study (n=19) 
Excluded (n=8) 
   Dropped out due to scheduling conflicts (n=2) 
   Based on ineligibility^ (n=6) 
Women who successfully completed the study (n=11) 
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Table 1.  
 
Participant demographics 









119 29.8 $50,000 18 Asian 16.9 Married/Living Together Unemployed No 35 8:17 
122 23.2 $20,000 17 Biracial 22.7 Married/Living Together Full-time Student Yes 44 7:05 
326 26.1 $12,000 19 Asian 20.4 Single Full-time Student No 43 8:24 
355 23.0 $12,000 17 White 26.0 Single Full-time Student Yes 67 7:05 
391 26.1 $30,000 18 White 23.2 Single Full-time Student No 48 8:05 
412 24.4 $15,000 18 White 23.3 Married/Living Together Full-time Student No 78 7:32 
474 26.2 $13,500 20 White 19.1 Single Full-time Student Yes 71 7:52 
533 23.9 $25,000 17 White 20.5 Single Full-time Student No 61 6:53 
696 23.2 $25,000 16 White 23.1 Married/Living Together Full-time Student Yes 52 8:22 
827 29.0 $32,000 18 White 35.6 Single Full-time Yes 54 7:16 
886 23.8 $20,000 17 White 25.4 Single Full-time Student Yes 42 7:41 
 
Mean/ 




Yes 54.1 7:41 
Standard 
Deviation 2.3 11,300 1.10  4.8    13.6 0:33 
 
M-E=Morningness-Eveningness Questionnaire; TST=Total Sleep Time; BMI calculated from participants’ weights and heights in the 
laboratory during consent visit; Participant numbers generated with online random number generator (http://www.random.org)
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Data Management 
Data were checked for missing variables prior to conducting analyses. One 
Psychomotor Vigilance Test (PVT) data point was missing on the first day of the study 
for a single participant due to participant non-adherence. One night of actigraphy data 
was missing on the third day of the recovery week due to participant non-compliance 
(she forgot to put the actigraph back on before she went to sleep). Pairwise deletion 
was used in these cases. One participant had 40 minutes of unscoreable data during 
the baseline overnight PSG due to technician error. Percentage of time spent in each 
sleep stage for this participant was based on the total sleep that was scored. On one of 
the post-fragmentation MSLT nap opportunities, a participant had an unscoreable 
recording because of PSG equipment malfunction after the nap opportunity had started. 
The participant’s MSLT score was based on the three usable naps. 
SPSS version 21.0 was used for data analysis. For all of the following analyses, 
a p<.05 was considered statistically significant, except in noted cases where a 
Bonferroni correction was used. Partial eta squared (η2p) (small=.01, medium=.06, 
large=.14), Cohen’s d (small=.2, medium=.5, large=.8), and Cramer’s V (small=.1, 
medium=.3, large=.5) were used to calculate effect sizes. 
Normality and Outliers 
Continuous variables were checked for skewness and kurtosis. PVT lapse 
frequency on the 7th day of the recovery period was slightly leptokurtic (Kurtosis/SE 
Kurtosis=3.3). Square root transformation was sufficient to achieve normality, and 
analyses were run on the transformed and untransformed variable. However, statistical 
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results did not differ; therefore, results are reported on untransformed values. Percent 
time spent in REM sleep on the sleep fragmentation night was slightly negatively 
skewed (Skewness/SE Skewness=-3.2) and leptokurtic (Kurtosis/SE Kurtosis=3.9). 
Square root and logarithmic transformations were insufficient to achieve normality, so 
non-parametric statistics were used when analyzing this variable. All other overnight 
PSG, actigraphic, MSLT, and POMS TMD data were normally distributed with no 
outliers.  
Results for Research Question #1 
RQ#1: How does a single night of experimentally-simulated postpartum sleep 
disturbance affect nocturnal melatonin release among healthy nulliparous 
women?  
The intra-assay coefficient of variation of the ELISA was 4.4%. The results did 
not support the hypothesis, that one night of postpartum-like sleep disturbance will 
cause a suppression of 6-sulphatoxymelatonin compared to the baseline night. A paired 
samples t-test was run to test for differences in 6-sulphatoxymelatonin (aMT6) 
concentration between baseline and sleep fragmentation nights. There was not a 
significant difference between aMT6 concentrations following the baseline (M=23.3, 
SD=13.5) and sleep fragmentation nights (M=25.0, SD=12.2; t[10]=.69, p=.51, d=.09) 
(see Figure 4). 
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Figure 4.  aMT6 concentrations during baseline and sleep fragmentation  
nights for individual participants.   
                 
 
Research Question #1: Supplemental Analyses 
 Because Figure 4 indicates individual differences in changes in aMT6 
concentration, participants change score (baseline aMT6 concentration - sleep 
fragmentation aMT6 concentration) was compared to selected demographics that either 
had sufficient variation within the sample to test for differences (income and baseline 
TST) or were of particular interest to circadian outcomes (use of oral contraception and 
M-E scores) to determine whether certain individual differences were driving differences 
in aMT6 changes. Correlations for continuous measures (income, M-E scores, baseline 
TST) and a t-test (for the categorical measure use of oral contraception) revealed no 

























Note: No significant differences between time points 
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Results for Research Question #2 
RQ#2: How does a single night of experimentally-simulated postpartum sleep 
disturbance affect sleep architecture among healthy nulliparous women? 
Following the American Academy of Sleep Medicine’s (AASM) standard scoring 
criteria, all overnight PSG studies were scored by two independent analysts (HMD and 
ALM), one who was blind to the participants’ identity (HMD). Blinding to the condition 
(whether it was the initial adjustment night, baseline, or sleep fragmentation night) was 
not possible because the recording montage differed between the adjustment and 
subsequent nights, and because the forced awakenings on the experimental night could 
be easily differentiated from the baseline night. However, the order of scoring of both 
participant and condition were randomized for HMD so that she did not score either 
participants or their PSG records chronologically. Minor discrepancies between HMD 
and ALM were settled by consensus so that the final agreement on the overnight stage, 
arousal, and event scoring was 100%. 
To determine whether the protocol was successful at simulating postpartum 
sleep disturbance (maintaining total sleep time and decreasing sleep efficiency during 
the experimental night compared to the baseline night), two paired samples t-tests were 
conducted to test the difference in total sleep time and sleep efficiency between the 
baseline and sleep fragmentation nights. There was not a significant difference in total 
sleep time between baseline (M=461min, SD=28min) and experimental nights 
(M=448min, SD=34min; t[10]=1.49, p=.17, d=.42). There was a significant decrease in 
sleep efficiency from baseline (M=90.9%, SD=6.1%) to experimental nights (M=74.4%, 
SD=3.9%; t[10]=9.31, p<.001, d=3.20). The protocol was also successful in awakening 
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each participant three times equally spaced throughout the night of approximately the 
same duration for each awakening (see Table 2). In sum, these data support that the 
sleep fragmentation protocol was successful in simulating postpartum sleep 
disturbance. 
Table 2.  
Descriptive information on sleep fragmentation night 
 Mean (min) SD (min) Range (min) 
Duration of 
Awakenings 
   
Awakening 1 32.9 3.2 29.8 - 38.7 
Awakening 2 31.8 1.8 29.6 - 34.7 
Awakening 3 32.4 2.5 29.9 - 37.1 
 Mean (hh:mm) SD (hh:mm) Range (hh:mm) 
Duration Between:    
Lights Out & 
Awakening 1 
2:06 0:09 1:48-2:21 
Awakenings 1 & 2 2:06 0:07 1:59-2:20 
Awakenings 2 & 3 2:06 0:07 2:00-2:19 
Awakening 3 & 
Lights On 
2:06 0:07 1:56-2:18 
 
Hypothesis 2a, that the percentage of time spent in stage N1 sleep will be 
increased in the experimental night compared to the baseline night, was not supported. 
A paired samples t-test using a Bonferroni correction (p=.012) was run to test for 
differences in time spent in stage N1 sleep between baseline and sleep fragmentation 
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nights. There was not a significant increase in the proportion of time spent in stage N1 
during the sleep fragmentation night (M=6.7%, SD=2.5%) compared to baseline 
(M=4.3%, SD=2.4%; t[10]=2.77, p=.02, d=.97) (see Figure 5).  
Hypothesis 2b, that the percentage of time spent in stage N2 sleep will be 
increased in the experimental night compared to the baseline night, was not supported. 
A paired samples t-test using a Bonferroni correction (p=.012) was run to test for 
differences in time spent in stage N2 sleep between baseline and sleep fragmentation 
nights. There was not a significant increase in stage N2 sleep on the sleep 
fragmentation (M=39.7%, SD=5.4%) night compared to baseline (M=43.5%, SD=8.3%; 
t[10]=1.83, p=.10, d=.55) (see Figure 5).  
Hypothesis 2c, that the percentage of time spent in stage N3 sleep will be 
reduced in the experimental night compared to the baseline night, was not supported. A 
paired samples t-test using a Bonferroni correction (p=.012) was run to test for 
differences in time spent in stage N3 sleep between baseline and sleep fragmentation 
nights. There was not a significant decrease in stage N3 sleep on the sleep 
fragmentation night (M=30.2%, SD=4.8%) compared to baseline (M=28.8%, SD=6.3%; 
t[10]=.64, p=.54, d=.24) (see Figure 5).  
Hypothesis 2d, that the percentage of time spent in REM sleep will be reduced in 
the experimental night compared to the baseline night, was not supported. With a 
Bonferroni correction (p=.012), there was not a significant decrease in REM sleep on 
the sleep fragmentation (Mdn=25.9%) night compared to baseline (Mdn =22.9%) with 
the Wilcoxon’s signed-rank test, Z=.44, p=.66, r=.13 (see Figure 5). 
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Figure 5. Time spent in each sleep stage between baseline and sleep 
fragmentation nights (Error bars represent SE). 
 
 
Research Question #2 Supplemental Analyses 
Because interesting patterns emerged through visual analysis of the data, 
comparisons were made to determine whether sleep onset latency following each of the 
three forced awakenings changed across the sleep fragmentation night. A repeated-
measures ANOVA was used to test for a polynomial shape across time. There was a 
significantly linear trend of decreasing sleep latencies across the night (F[2]=11.2, 
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Figure 6. Sleep onset latency after each successive forced awakening on the 
sleep fragmentation night (Error bars represent SE). 
 
 
Results for Research Question #3 
RQ#3: How does a single night of experimentally-simulated postpartum sleep 
disturbance impact daytime sleepiness among healthy nulliparous women? 
The Multiple Sleep Latency Test (MSLT) was scored in real-time per standard 
scoring criteria (Littner et al., 2005) and was then also examined 3 months after data 
collection was completed independently by both ALM and HMD. Both were blind to 
whether the test was pre or post sleep fragmentation and their order was randomized to 
prevent an order effect of systematic changes across participants. HMD had 
administered 2% and ALM administered 56% of the MSLT nap opportunities. The 
retrospective scores were then compared to each other and to the original real-time 
scores. There was a 47.7% agreement rate on each nap opportunity between HMD 





















 Note: Significant decreasing linear trend 
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between the original and retrospective scores: when the original MSLT was 
administered by a research assistant, there was greater discrepancy between the 
original and retrospective scores. ALM administered 86% of the baseline MSLT nap 
opportunities; research assistants administered 89% of the post-fragmentation MSLT 
naps opportunities. To avoid errors in the planned comparisons due to systematic 
differences in scoring, MSLT scores were retrospectively changed according to rules 
described in Appendix A. 
In accordance with standard criteria, the baseline week of actigraphy 
simultaneously served as monitoring to ensure sufficient sleep prior to the MSLT, 
specifically that the night prior to the MSLT was representative of the participants’ 
normal sleep (Littner et al., 2005). A t-test performed comparing the average total sleep 
time of the first six days of the baseline week (M=462, SD=33) to the seventh day (the 
night before the MSLT) (M=454, SD=53) confirmed there was no significant change in 
total sleep time (t[10]=.65, p=.53, d=.19). 
The hypothesis that sleep fragmentation would cause greater daytime sleepiness 
on an MSLT compared to baseline was not supported. A paired samples t-test was run 
to test for differences between baseline and post-sleep fragmentation MSLT scores. 
There was a significant decrease in objective sleepiness (an increase in the MSLT 
score) between the day following baseline (M=13.1, SD=3.54) and the day following 
sleep fragmentation nights (M=16.3, SD=3.51; t[10]=2.83, p=.02, d=.92) (see Figure 7). 
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Figure 7. MSLT average sleep onset latencies between baseline and sleep 
fragmentation nights for each individual participant (Error bars represent SD).
 
Research Question #3: Supplemental Analyses 
In order to determine whether sleepiness at certain times of the day was driving 
the overall improvement in sleepiness, supplemental analyses were made comparing 
the MSLT scores of the four individual naps from baseline to post-sleep fragmentation. 
A 2 (condition: baseline vs. post-fragmentation) x 4 (each individual nap) repeated-
measures ANOVA was conducted. A significant main effect of condition was qualified 
by a significant condition x nap interaction, F(3)=5.65, p=.004, η2p =.39.  Post-hoc 
dependent t-tests using a Bonferroni correction (p=.012) determined that there was a 
significantly shorter sleep onset latency during the baseline MSLT for the fourth nap 























Note: Significant increase between baseline and post-fragmentation 
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Figure 8. MSLT sleep onset latencies for individual nap opportunities between 





 Because Figure 7 indicates some participants had increases and others had 
decreases in MSLT scores, participants change score (baseline MSLT – post-sleep 
fragmentation MSLT) was compared to selected demographics (income, birth control pill 
use, M-E questionnaire, and baseline TST) to determine whether certain individual 
differences were driving differences in MSLT changes. Correlations for continuous 
measures (income, M-E scores, baseline TST) and a t-test (for the categorical measure 
use of oral contraception) revealed no relation between any of these demographic 
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Results for Research Question #4 
RQ#4: How does a single night of experimentally-simulated postpartum sleep 
disturbance impact the next week’s sleep, performance, and mood among 
healthy nulliparous women? 
Actigraphy Total Sleep Time 
Six participants took daytime naps during the study; for these participants, 24-
hour sleep time was used. Specifically, one participant napped on two days during the 
baseline week, two participants napped on two days during the recovery week, and 
three participants napped on one day during the recovery week.  
In order to test the hypotheses that experimental sleep disruption will cause 
increased actigraphy-measured total sleep time on the proceeding at-home recovery 
night, compared to baseline at-home total sleep time, and total sleep time will decrease 
to baseline levels after the first recovery night, first a repeated-measures ANOVA with 
total sleep time as the dependent variable and time since beginning of the study until 
the first in-lab day (baseline) was conducted to determine whether total sleep time 
changed across the baseline week. There was no significant change in total sleep time 
across the baseline week, F[6]=.55, p=.77, η2p =.05 (see Figure 9). These data were 
averaged and a paired samples t-test was used to test for differences in the average 
total sleep time between baseline and the total sleep time the night after the sleep 
fragmentation protocol. The results did not support the hypothesis; there was not a 
statistically significant change in total sleep time between the baseline average (M=461, 
SD=33) and the night after sleep fragmentation (M=463, SD=83; t[10]=.12, p=.91, 
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d=.03). Given the null findings, the second part of the hypothesis that total sleep time 
will decrease to baseline levels after the first recovery night, was not tested. 




In order to test the hypotheses that experimental sleep disruption will cause 
worse performance on a psychomotor vigilance test (PVT) on the morning after 
experimental sleep fragmentation compared to baseline condition, and will gradually 
improve to baseline levels across the recovery week, first two repeated-measures 
ANOVAs with frequency of PVT lapses as the dependent variable and either time from 
beginning of the study until the first in-lab day (baseline) or time since sleep disruption 
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changed across baseline and recovery weeks. There was no significant change in 
frequency of PVT lapses across the baseline (F[6]=2.72, p=.08, η2p =.23) or recovery 
weeks (F[7]=1.31, p=.26, η2p =.12) (see Figure 10).  
Given the lack of change in frequency of PVT lapses within each of the baseline 
and recovery weeks, the data were averaged and a paired samples t-test was used to 
test for differences in the average frequency of PVT lapses between baseline and 
recovery weeks. By using the averages of values across baseline and recovery weeks, 
the comparisons are more robust to daily performance variations within a week. The 
results supported a reduction in performance after sleep fragmentation; there was a 
statistically significant increase in frequency of PVT lapses (M=2.72, SD=1.76) 
compared to the baseline average (M=1.62, SD=1.83; t[10]=2.98, p=.01, d=.61). 
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Figure 10. Frequency of PVT lapses across baseline and post-fragmentation weeks 




In order to test the hypotheses that experimental sleep disruption will cause 
higher POMS total mood disturbance scores the day after experimental sleep 
fragmentation compared to baseline condition, and will gradually improve to baseline 
levels across the recovery week, first a repeated-measures ANOVA with POMS TMD as 
the dependent variable and time since sleep disruption as the independent variable was 
conducted to determine whether POMS TMD scores changed across the post-
fragmentation week. As only one baseline measure was taken for this survey, tests for a 
change in baseline score were not performed. After a Greenhouse-Geisser correction 
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POMS TMD scores across the post-fragmentation week (F[3]=.37, p=.65, η2p =.04) (see 
Figure 11).  
Given the lack of significant change in POMS TMD scores across the post-
fragmentation weeks, those data were averaged and a paired samples t-test was used 
to test for differences in between baseline POMS TMD score and the average POMS 
TMD score across the post-fragmentation week. There was a statistically significant 
increase from baseline POMS TMD scores (M=-1.00, SD=7.10) compared to the post-
fragmentation week average (M=8.55, SD=12.9; t[10]=2.40, p=.037, d=.92) (see Figure 
11). 
Figure 11. POMS TMD between baseline and after experimental sleep 
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Research Question #4: Supplemental Analyses 
While analyzing the actigraphy sleep recovery data, there was a trend observed 
in napping behavior, with more frequent naps observed after sleep fragmentation. 
Therefore, the prevalence of napping before and after sleep fragmentation was 
analyzed statistically. A McNemar’s test was conducted to determine whether there was 
a change in number of participants who napped before and after experimental sleep 
fragmentation. During the baseline week, 9.1% of participants napped compared to 
45.5% of participants who napped during the recovery week, however, this was not a 
statistically significant difference, p=.22, Cramer’s V=.29. Of the naps taken during the 
recovery week, 42.9% were taken the day after the recovery night from the MSLT. 
After finding significant differences on the POMS total mood disturbance scale 
between baseline and the average of POMS scores post-fragmentation, paired samples 
t-tests were conducted on each of the seven POMS subscales to understand 
specifically which components of mood were affected by the sleep fragmentation. There 
was a significant increase in the fatigue subscale (t[10]=2.38, p=.04, d=.73) and 
decrease in the vigor subscale (t[10]=4.26, p=.002, d=1.59) after sleep fragmentation 
compared to baseline. There was no significant change on the tension, depression, 
anxiety, or confusion subscales (see Figure 12). 
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 Figure 12. POMS subscale scores at baseline and the average of subscales  
after sleep fragmentation (Error bars represent SE). 
 
*p<.05; **p<.01 
Planned Supplemental Analyses 
Comparison to Postpartum Data 
 There were changes to PVT performance and mood in the current study, so 
these data were compared to existing postpartum PVT performance and mood at the 
earliest recording period. 
PVT Performance 
 To determine whether there were any performance differences between early 
postpartum women and nulliparous women in the current study, an existing database 
with frequency of PVT lapses averaged across postpartum week 2 among primiparous 
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sleep fragmentation in the current study’s sample. The lapse frequency for primiparous 
women was positively skewed, so was square root transformed. Levene’s test was 
significant, so equal variances were not assumed. An independent t-test indicated the 
lapse frequency was significantly greater for postpartum women (M=5.80, SD=4.69) 
than nulliparous women in the current study (M=2.72, SD=1.76; t[25.2]= 3.32, p=.003, 
d=.87). 
Mood 
To determine whether there were any mood differences between early 
postpartum women and nulliparous women in the current study, existing data of POMS 
TMD scores at postpartum week 3 (the earliest time POMS was administered) among 
primiparous women were compared to the average POMS TMD scores post-
experimentally induced sleep fragmentation in the current study’s sample. The POMS 
TMD scores for primiparous women were positively skewed, so these data were square 
root transformed. POMS TMD scores were not significantly different between 
postpartum women (M=21.4, SD=24.4) and nulliparous women in the current study 
across the recovery week (M=8.55, SD=12.9; t[77]= 1.71, p=.09, d=.66). 
Discussion 
 The primary goal of this study was to understand the discrete impacts of 
postpartum sleep disturbance on sleep architecture, mood, circadian rhythm amplitude, 
daytime sleepiness, and recovery. The average age of the current sample (25.4 years) 
was consistent with the average age of first time mothers in the U.S. (25.0 years) 
(Laughlin, 2011). However, there were fewer women who were married or cohabitating 
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(36.4%) compared to first time mothers in the U.S. (76.3%) (Martinez, Daniels, & 
Chandra, 2012). Furthermore, this sample was highly educated, with 100% of 
participants earning at least a Bachelor’s degree, compared to 24% of all mothers in the 
U.S. (Laughlin, 2011). 
A functional model of postpartum sleep fragmentation was established; women 
had significantly lower sleep efficiency on the sleep fragmentation night compared to 
baseline. The current sample’s PSG-recorded average sleep efficiency (74.4%) was 
slightly lower than the actigraphically-recorded sleep efficiency of women in the second 
week postpartum (79.7%) (Montgomery-Downs et al., 2010). In an attempt to isolate the 
impacts of sleep fragmentation from total sleep time, the time in bed of each participant 
from baseline to sleep fragmentation night was preserved. This resulted in a total sleep 
time that was only slightly higher than that previously reported among postpartum 
women (M=7.46hr±0.56, M=7.2hr±0.95, respectively, Cohen’s d=0.33).  
Results indicated no changes in 6-sulphatoxymelatonin (aMT6), time spent in 
nocturnal sleep stages, and total sleep time after sleep fragmentation compared to 
baseline. There was a significant decrease in daytime sleepiness after fragmentation 
compared to baseline, specifically on the fourth and final MSLT nap opportunity. 
Performance and mood decrements were seen the week after sleep fragmentation 
compared to baseline. Interpretations of these findings are described in respective 
sections below. 
EFFECTS OF A POSTPARTUM SLEEP SCHEDULE   65 
 
Melatonin 
The averages of aMT6 concentration among the current sample are consistent 
with overnight aMT6 concentrations reported in previous studies. The current sample 
had pre- and post- concentrations of 23.3 ng/ml (SD=13.5) and 25 ng/mg (SD=12.2), 
respectively, which compares well to creatinine adjusted 6-SMT concentrations found in 
premenopausal women (M=28.5 ng/mg, SD=19) (Schernhammer et al., 2004). 
The concentration of aMT6 among the current sample did not change between 
baseline and sleep fragmentation nights, a finding that did not support the hypothesized 
decrease in aMT6 concentration on the sleep fragmentation night compared to baseline. 
However, the hypothesis was based on differences in melatonin levels among 
postpartum women (Thomas & Burr, 2006) and other populations who experienced 
fragmented sleep (Hernandez et al., 2007; Sack et al., 2007) in naturalistic settings, not 
in a highly controlled laboratory. Kavčič and colleagues (2011) did measure the 
response of melatonin in the laboratory, but they used an experimental sleep 
deprivation protocol, not sleep fragmentation, and their subjects were exposed to light at 
night, whereas the current protocol was careful to only use a very dimly lit environment 
in order to parse out the effects of the fragmentation from the light exposure. 
Conversely, results were consistent with recent literature that fragmented the 
sleep of healthy men for one night, with preserved total sleep time, and found no 
changes in plasma melatonin concentration (Gonnissen, Hursel, Rutters, Martens, & 
Westerterp-Plantenga, 2013). This study also utilized a sleep fragmentation protocol 
that had longer periods of consolidated sleep (90 mins of sleep before participants were 
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awakened); however, the awakenings were very brief (about 2 minutes – enough time 
for the participant to confirm awakening by shutting off an alarm). There were no 
changes in posture or light exposure during these awakenings. 
Based on the existing literature, there are two distinct but possible conclusions 
that could be drawn to interpret the findings. The first is that the associations previously 
found between fragmented sleep and reduction in concentration of melatonin is largely 
due to environment influences, such as light at night, or postpartum hormonal changes. 
The second is that multiple nights of sleep fragmentation are necessary in order to 
observe the physiological changes in melatonin. It is likely that a combination of these 
factors account for some of the suppression of melatonin found among sleep 
fragmented populations.  
There are only a couple of studies that have examined how sleep patterns 
change during the postpartum period, and findings are inconclusive. The lack of existing 
evidence is likely due to the difficulties in the longitudinal data collection from pre-
pregnancy, pregnancy, and the postpartum period that would adequately address this 
question; such a longitudinal study has never been done. Wolfson, Crowley, Anwer, & 
Bassett (2003) show no changes in bedtime, but later rise times by an average of 52 
minutes between the end of pregnancy and 2-4 weeks postpartum. This supports the 
current study’s protocol of keeping bedtimes constant, but extending rise times. 
Recently, using a small sample (n=12) of women who had a history of major depression 
disorder, Sharkey, Pearlstein, & Carskadon (2013) characterized changes in circadian 
phase from the third trimester of pregnancy to the 6th postpartum week. There was an 
average phase delay of 42 minutes from pregnancy to postpartum; six women had 
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phase delays >1 hour. However, there were no changes in actigraphically-recorded 
bedtimes and wake times, in contrast to the findings of Wolfson and colleagues. Further 
research in the change of sleep periods and circadian phase during the postpartum 
period is warranted. 
Sleep Architecture 
The current study’s sleep fragmentation protocol resulted in no changes in any of 
the nocturnal sleep stages. This finding counters the literature on experimental sleep 
fragmentation among healthy subjects. Previous studies have reliably demonstrated 
sleep fragmentation increases in stage N1 and decreases in stage N3 and/or REM 
(Bonnet, 1985; Roehrs et al.,1994). However, these studies have used sleep 
fragmentation protocols that simulate sleep-fragmenting disorders such as obstructive 
sleep apnea. In these protocols, participants are awakened every couple of minutes for 
only brief moments of time, throughout the entire night. At the time of the proposal, the 
current study was the first that was known to experimentally simulate longer periods of 
consolidated sleep, with longer periods of wake. However, recently one other group 
created a sleep fragmentation protocol that allowed for longer periods of consolidated 
sleep. Gonnissen et al. (2013) interrupted the sleep of healthy males about every 90 
minutes throughout the night (5 awakenings in total). However, the awakenings were 
brief; as long as it took participants to turn off an alarm (about 2 min). The results 
showed a decrease in stage REM sleep at the expense of an increase in stage N2 
sleep. This protocol was the most similar to that used in the current study, but still took 
advantage of more frequent awakenings. It is possible current results did not show 
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changes in time spent in stage N3 or REM sleep because there were too few 
awakenings.  
While working as the night technician for the sleep fragmentation night, ALM 
noticed a trend in real-time of decreasing sleep onset latencies after each of the three 
scheduled awakenings. This observation provided the impetus for analyzing the 
supplemental data of the changes in sleep onset latencies from each awakening across 
the night. The statistical analyses supported this observation, indicating subjects have a 
higher sleep propensity after each progressive awakening. This effect of time of night on 
sleep propensity has been previously reported in sleep fragmentation protocols where 
participants were awakened every two hours (Helmus et al., 1996; Nykamp et al., 
1999). Furthermore, in their seminal study, Dijk and Czeisler (1995) used a forced 
desynchrony protocol of a 28 hour rest-activity cycle in an environment free of time cues 
to study the circadian regulation of sleep propensity independent of the homeostatic 
sleep drive. Sleep propensity was heightened during 2200 and 0600 hours, regardless 
of when the sleep period occurred. The current findings provide further support for a 
circadian modulation (Process C) of sleep propensity in the context of the two-process 
model of sleep regulation. As the latency to sleep onset was at a time of night when the 
most hours of sleep were accrued, it is not reasonable to assume that only the 
homeostatic sleep drive (Process S: the regulation of sleep propensity on the basis of 
prior wake time) regulates sleep propensity. The interaction between the two processes, 
the circadian timing and homeostatic sleep drive, explains the consolidated nocturnal 
sleep period. The homeostatic sleep drive is prominent in the first few hours of nocturnal 
sleep, weakening across the night as more sleep is accrued, at which point the 
EFFECTS OF A POSTPARTUM SLEEP SCHEDULE   69 
 
circadian sleep drive predominantly takes over, allowing sleep to continue (Dijk & von 
Schantz, 2005).   
Daytime Sleepiness 
Results did not support an increase in objective daytime sleepiness after sleep 
fragmentation. Conversely, women had a decrease in daytime sleepiness, and while 
this decrease was not significant, it was supported by a large effect size (Cohen’s 
d=0.92). However, both the average baseline and post-fragmentation MSLT scores 
were >10, a score that is considered normative among a healthy population (Afifi et al., 
2005). So while the scores non-significantly increased, the meaningfulness of the 
change in scores from a clinical perspective in diagnosing daytime sleepiness is 
negligible.  
The result of no difference in objective sleepiness before and after sleep 
fragmentation was unexpected when taken in the context of the literature on the impact 
of sleep fragmentation with daytime sleepiness. Sleep disorders that are characterized 
by sleep fragmentation cause daytime sleepiness (Benbadis, 2005). Furthermore, 
experimental sleep fragmentation among healthy populations in a study design that 
carefully extended sleep periods in accordance with increased nocturnal wakefulness to 
ensure total sleep time did not differ, caused significantly decreased MSLT scores by 
4.5 mins after a single night of fragmentation (Roehrs, 1994). However, this study 
fragmented sleep with an auditory tone every 2 minutes, a procedure that altered sleep 
architecture; participants spent significantly more time in the lighter stages of sleep 
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(stages N1 and N2) and less time in stage N3 and REM sleep. This change in sleep 
architecture is something the current procedure did not achieve. 
One potential explanation for the inconsistency between current results and 
previous literature of the impact of sleep fragmentation on daytime sleepiness is there 
were no changes in stage N3 sleep in the current study. The reduction in percentage of 
the sleep period spent in stage N3 in previous studies may explain the associated 
increase in daytime sleepiness in the aforementioned studies. There were no changes 
in total sleep time, but decreases in stage N3 sleep and MSLT scores when sleep was 
experimentally fragmented to cause a transient increase in blood pressure or heart rate 
but no visible EEG arousal (Martin, Wraith, Deary, & Douglas, 1997). When gaboxadol, 
a stage N3-enhancing drug, was administered prior to each night of a 4-night sleep 
restriction protocol (5 hours of sleep each night), total sleep time did not differ between 
the placebo and gaboxadol groups, but stage N3 was significantly enhanced in the 
gaboxadol group on each night. While both placebo and gaboxadol groups had 
decreased MSLT scores from baseline to after the 4-night sleep restriction protocol, the 
decrease was significantly less for the gaboxadol compared to placebo (Walsh et al., 
2008). Taken in context, given the current findings of minimal changes in sleep 
architecture, it is likely not surprising there were no effects on MSLT scores. 
However, there is also support for the idea that the effect of sleep fragmentation 
on daytime sleepiness is mediated by the disturbance of sleep continuity as opposed to 
changes in sleep stages. The results of a clustered experimental sleep fragmentation 
(disturbances every 30 sec for 30 min, followed by 60 min uninterrupted sleep) protocol 
indicated greater portions of time spent in stage N3 sleep compared to subjects whose 
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sleep was fragmented every 90 sec throughout the night. However, there were no 
differences in MSLT scores between the clustered or regular sleep fragmentation, 
despite the differences in sleep architecture (Martin, Brander, Deary, & Douglas, 1999). 
Similarly, another study used a sleep fragmentation protocol in which participants’ sleep 
was fragmented for two nights approximately 70 times each night. Results showed no 
difference in sleep architecture between the baseline and experimental nights, however, 
there was a significant decrease in MSLT scores (Stepanski, Lamphere, Roehrs, Zorick, 
& Roth, 1987). Interpretation of the current results lend support to either the importance 
of alterations to sleep stages in causing daytime sleepiness or the necessity of more 
frequent nocturnal awakenings to cause sufficient interruption of sleep continuity to 
reduce daytime sleepiness. 
After spending 3 consecutive nights in the laboratory, the post-fragmentation 
MSLT was the final laboratory-based procedure in the protocol. It cannot be discounted 
that participants may have been less likely to fall asleep because they were excited they 
were nearing the end of the study. On the fourth and final nap of the post-fragmentation 
MSLT, 81.8% of participants did not fall asleep. This compares to 27.3% who did not fall 
asleep on the final nap of the baseline MSLT. While this likely does not explain the lack 
of decrease in MSLT scores as a result of sleep fragmentation, it may explain the 
significant increase in MSLT scores after sleep fragmentation. 
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Post-Fragmentation Week 
Total Sleep Time 
Contrary to the hypothesis, nocturnal total sleep time monitored for one week 
post-sleep fragmentation showed no difference in total sleep time the night immediately 
after sleep fragmentation compared to baseline. There was also no change in total 
sleep time across the post-fragmentation week. Supplemental data analysis on naps 
found no statistically significant difference in naps between baseline and recovery 
weeks, and the majority of the naps taken occurred the day after the first recovery night 
from sleep fragmentation. It’s possible that the lack of change in sleep stems from the 
participants’ instructions to sleep ad libitum during the recovery week, compared to the 
consistent sleep schedule with at least 8 hours in spent in bed each night attempting to 
sleep during baseline. This was not required during the recovery week, so it is unknown 
whether participants merely did not physiologically need to extend their sleep after sleep 
fragmentation, or they chose not to extend their sleep (for potentially social or work 
reasons).  
Performance 
Neurocognitive performance, assessed each morning of the study protocol, 
showed a significant difference from pre- to post-fragmentation, lending support to the 
hypothesis of a decrease in neurocognitive performance after sleep fragmentation 
despite no difference in total sleep time. These results provide causal evidence that 
postpartum-like sleep fragmentation has a negative impact on performance independent 
of total sleep time. There was no trajectory of recovery among these participants; 
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statistically, the PVT values did not change across the post-fragmentation week. As 
Banks et al. (2010) reported, a 10 hour time in bed protocol the night after chronic sleep 
restriction was insufficient to return performance to baseline values. If participants in the 
current study did not allow for enough time devoted to sleep after the sleep 
fragmentation night, their performance data may be a reflection of a buildup of sleep 
debt that has not been adequately repaid. 
Supplemental analyses compared performance of the current sample of 
nulliparous women with primiparous women in the second postpartum week and found 
postpartum women had significantly worse performance than nulliparous women. This 
difference is most likely an effect of the impact of cumulative sleep disturbance on 
performance among postpartum women (Insana, Williams, & Montgomery-Downs, 
2013), as the postpartum women were already in their second postpartum week. 
Furthermore, women experience sleep disturbances during the third trimester (Wilson et 
al., 2011; Wolfson et al., 2003), which means they are already entering the postpartum 
period with sleep debt, as opposed to the current sample who were well rested prior to 
their sleep fragmentation night. 
Mood 
 Results indicate that mood, as scored through the POMS total mood disturbance, 
worsens after experimental sleep fragmentation. At baseline, participants had an 
average score of -1.00 (lower scores are indicative of better mood), which rose to an 
average of 8.55 across the post-fragmentation week. Supplemental analyses comparing 
these data to POMS scores of healthy postpartum women 2 weeks after birth found no 
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significant difference between groups. However, the p-value was approaching 
significance and there was a moderate effect size (Cohen’s d=0.66) trending towards 
postpartum women reporting worse mood. Yet, these differences may not be a function 
of differences between postpartum women and non-postpartum controls, as another 
validation study of the POMS on a healthy population of 208 adult women found 
averages POMS scores of 20.3 (SD=33.1) (Nyenhuis, Yamamoto, Luchetta, Terrien, & 
Parmentier, 1999).  
The substantially lower baseline mood scores of the women in the current study 
compared to the healthy sample may be an effect of age; in the Nyenhuis et al. (1999) 
study, the women were on average 44 years (range 18-94) compared to the current 
study’s 25 years (range 23-30). Previous literature using the POMS to measure mood 
report age-related declines in mood states (Gibson, 1997). Alternatively (or additionally), 
the lower baseline scores may be an effect of sleep, as chronic sleep restriction can 
cause mood disturbances (Dinges et al., 1997). The women in the current sample were 
screened to be healthy sleepers, and they averaged 7 hours 41minutes of total sleep 
time during baseline, approximately 20 minutes more than that obtained by 25-year olds 
(Ohayon, Carskadon, Guilleminault, & Vitiello, 2004). They also obtained consistent 
sleep periods during the baseline week, another aspect of sleep that has been found to 
improve mood (Takasu, Takenaka, Fujiwara, & Toichi, 2012). 
 The supplemental analyses suggest it may not be the obvious dimensions of 
mood (e.g. depression, anxiety) that are impacted. When subscales were analyzed, 
there were significant changes in fatigue (increased) and vigor (decreased) post-
fragmentation. However, no significant changes were noted in tension, depression, 
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anxiety, or confusion. This is consistent with previous work that found chronic sleep 
restriction impacts POMS total mood disturbance scores, and specifically subscales of 
fatigue, vigor, confusion, and tension (Dinges et al., 1997). However, it is inconsistent 
with the postpartum depression literature; based on the occurrence of postpartum 
depression, there would be an expected increase in the depression subscale after one 
night of sleep fragmentation. As this was not the case, it is speculated the relation 
between sleep and postpartum depression is a result of the longer-term sleep 
fragmentation postpartum women experience (that was not modeled in the current 
study), potentially combined with sleep quality during pregnancy (Wilson et al., 2011; 
Wolfson et al., 2003). Environmental factors, such as low levels of social support or a 
recent stressful event (Robertson et al., 2004) or changes in concentrations of sex 
steroids after parturition (Russell et al., 2000) may also be contributing factors of 
postpartum mood disturbances and warrant further research. 
Limitations 
 The study had a number of limitations, including the small sample size. Although 
the sample size was consistent with previous literature that have similar experimental 
sleep fragmentation protocols, it limited analyzing whether individuals who did have 
changes in dependent variables from baseline to sleep fragmentation nights differed 
from those who did not have changes in dependent variables on demographic 
measures, for instance. Individual differences such as these may give insight into why 
some women were more affected by the sleep fragmentation protocol than others. 
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Another limitation may have been the rigorous selection criteria. While these 
criteria were put in place to reducing confounding factors on the outcome variables of 
interest, there were a large proportion of women who were excluded from continued 
participation because they did not meet minimum scores on the MSLT (n=4). However, 
their baseline actigraphy sleep appeared healthy. Participants who were more resistant 
to the effects of sleep disturbances may have been unintentionally selected. Those who 
were excluded may be more sensitive to the effects of sleep disturbances, and may 
have been impacted more by the sleep fragmentation.  
Finally, the awakenings may not have been long enough to model the early 
postpartum period. While the protocol followed the available literature in guiding the 
number and duration of awakenings, recent unpublished findings from our lab found 
mothers with very young infants (<1 month) self-reported an average of 3.6 awakenings 
each night, and each awakening was an average duration of 55 minutes. This is over 20 
minutes longer than the protocol used in the current study. These unpublished data also 
found that as the infant ages, the duration of the awakenings shortens. However, it 
supports early postpartum longer nocturnal awakenings. 
Future Directions 
Future research should expand upon this sleep fragmentation protocol to 
determine what factors may contribute to the impairment that was generally not seen in 
this study. Some additions to the protocol could include multiple nights of sleep 
fragmentation in an attempt to assess the effects of a chronic postpartum sleep 
fragmentation as opposed to an acute focus.  
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Furthermore, variations in nocturnal activities and lighting levels could be 
assessed to determine their impact on physiological measures and performance 
outcomes. The current protocol carefully kept subjects out of light levels that could 
disrupt their melatonin levels and the focus of the awakenings was solely on infant 
caregiving. This was in order to isolate the impact of the sleep fragmentation. Future 
studies should work to understand how the differences in activities and behaviors 
postpartum women engage in may be negatively impacting their sleep. Unpublished 
data from our lab indicate 81.5% of women reported using an electronic device 
(television, computer, cell phone, backlit tablet, or a combination of these) during 
nocturnal awakenings and 89% of women are using at least one extra light source 
during caregiving, but their light sources vary widely in intensity. Examining the impact 
of these behaviors, both in field-based and laboratory settings, are important next steps 
to understanding maternal sleep disturbances. 
Finally, more research should be directed towards the impact of postpartum 
changes in physiology on sleep and circadian rhythms. Early evidence suggests 
hormonal changes in postpartum women may be contributing to changes in circadian 
rhythms and sleep architecture. Feeding method may be moderating some of the 
hormonal changes, as breast-feeding promotes the release of prolactin, a hormone 
strongly associated with sleep. However, much of the impact of postpartum 
physiological changes on sleep remains unclear. 
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Conclusion 
A complex process of physiological and environmental changes during the 
postpartum period confounds our understanding of the discrete impacts of postpartum 
sleep fragmentation. The present study sought to isolate the effects of postpartum sleep 
fragmentation on sleep architecture, nocturnal melatonin, mood, daytime sleepiness, 
performance, and recovery by manipulating the sleep of childless women in the 
laboratory to model postpartum sleep fragmentation. The postpartum reduction in sleep 
efficiency with no change to total sleep time was successfully modeled. No differences 
were found in nocturnal melatonin concentration or time spent in sleep stages between 
baseline and sleep fragmentation nights. A significant decrease in daytime sleepiness 
after fragmentation compared to baseline was observed, specifically on the fourth and 
final MSLT nap opportunity. There was no change in total sleep time the night after 
sleep fragmentation. Sleep fragmentation did cause performance and mood decrements 
across the week post-sleep fragmentation compared to baseline. Results suggest no 
physiological changes of a single night of simulated postpartum sleep fragmentation, 
but significant deficits in mood and neurobehavioral performance. These findings 
suggest that the mere disruption of sleep continuity in the absence of the measured 
physiological changes is sufficient to cause poorer mood and performance, stressing 
the importance of examining both subjective and objective measures in sleep 
fragmented populations.  
This study expands the literature by providing a basic understanding of the acute 
effects of postpartum sleep fragmentation. It was also the first to model this sleep 
disturbance using childless women, establishing the feasibility of using childless women 
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in future studies to assess chronic sleep fragmentation or alterations in the nocturnal 
environment, such as the impact of light and electronic use at night. 
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Center for Epidemiologic Studies Depression Scale (CES-D) 
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MSLT score differed by ≤1 
min (n=15) 
Retained original score 
A research assistant 
administered the nap (n=40 
naps) 
 
Retained original score A research assistant 
administered the nap (n=21 
naps) 
3-way disagreement 
between original, HMD, 
and ALM retrospective 
scores (n=9 naps) 
Retained original score 
HMD and ALM 
retrospective scores were 
in 100% agreement (n=12 
naps) 
Original score changed to 
retrospective score 








ALM administered nap 
(n=12 naps) 
 
Retained original score A research assistant & 
HMD retrospective 
scores were in 100% 
agreement (n=19 naps) 
MSLT score differed by >1 
min (n=13; corresponds to 52 
naps) 
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MCBEAN’S SPAGHETTI SAUCE 
2¼ lbs  lean ground beef 
2 cans (10 oz.)  tomato soup 
1 can  (14 oz.)  Hunt’s tomato sauce 
2 Tbsps.  Lea & Perrins Worcestershire sauce 
3-5 drops  Tobasco sauce 
½ tsp.  black pepper 
2 tsp.  oregano 
1 tsp.  onion salt 
3 cloves  garlic, pressed 
4 oz.  button mushrooms, minimum 
3 Tbsps.  extra virgin olive oil 
1. In a large frying pan, brown the lean ground beef (at medium to medium high) 
until there are next to no juices on the bottom of the frying pan. 
2. Combine the tomato soup, the tomato sauce, the Worcestershire sauce, the 
Tobasco sauce, pepper, oregano, onion salt and garlic into the browned beef. 
3. In a separate smaller frying pan, and usually at the same time or slightly behind 
the browning of the lean ground beef, sauté the mushrooms (over low heat) in 
the olive oil.  Just brown the mushrooms, do not overcook!  Add the mushrooms 
to the sauce, when ready. 
4. Simmer for about 1 hour.  If you want to simmer longer, add small quantities of 
water when necessary. 
Makes 8 servings. 
 
